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4SUMMARY
SUMMARY
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer 
death among females. Radiotherapy (RT) halves the recurrence risk and reduces the risk 
of breast cancer death with nearly 20% after breast conserving surgery. However, evidence 
accumulates that breast RT is associated with major, even lethal side effects like cardiac 
disease and cancer induction, especially to lungs and heterolateral breast. The purpose 
of this thesis is to optimize the treatment technique for whole breast irradiation (WBI) with 
the aim to reduce irradiation of organs at risk (OARs) while providing an adequate and 
homogeneous dose to the target. Attention was given to feasibility of new techniques and 
portability to other centres.
In standard supine position, the breast spreads over the thoracic wall enwrapping heart 
and lungs leading to suboptimal anatomy to achieve a homogeneous dose to the breast 
and to reduce dose to the OARs. Prone position provides advantages; it elongates the 
breast away from the intra-thoracic region, narrows the breast and stretches skin folds. In 
the first part of this thesis, our aim was optimizing radiation techniques for both positions. 
Multi-beam intensity modulated RT was the best technique in supine position to provide a 
conformal dose to the target while avoiding heart and lungs. Differences between various 
techniques were less pronounced in prone position. Overall, prone positioning yielded 
better results: better dose conformity to the target, superior lung sparing and improved heart 
dose metrics in all patients with large breasts (chapter 3). Our further research focused on the 
validation of prone techniques with special attention to patients who required left-sided WBI. 
The second part of this thesis involves the comparative clinical assessment of the best 
prone and supine technique. Of concern was the daily reproducibility of the CT-simulat-
ed position during treatment. Daily cone beam CT (CBCT) was the desired technique but 
the existing CBCT parameters weren’t optimized for breast RT. Therefore, we optimized 
the CBCT acquisition parameters to improve surface reconstruction, decrease radiation 
exposure and enhance clinical practicality (chapter 4). 
A comparative assessment was performed using a randomized controlled trial comparing 
prone and supine positions in 100 large breasted patients. The trial confirmed earlier 
dosimetric studies. Prone WBI was able to improve target dose distribution, heart and lung 
sparing. Prone position was associated with significantly less acute toxicity. Moist desqua-
mation was reduced from 20% in supine to 6% in prone position. Dermatitis, edema and 
pain were less frequent and less severe in the prone treated cohort. This study provides 
level-I evidence of replacing supine by prone WBI for large breasted patients (chapter 5).
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In the third part of the thesis, we focused on optimizing heart dose metrics in the prone po-
sition. First, we investigated the effects of deep inspiration breath hold (DIBH), a technique 
successfully used in supine position, to lower heart dose in prone left-sided WBI. In silico 
assessment showed that prone DIBH reduced heart dose while maintaining the benefits of 
prone position on lung sparing (chapter 6). The reproducibility of prone DIBH was studied 
in 30 patients. CT-simulation and respiratory monitoring data were analysed, all pointing to 
the feasibility and good reproducibility of the DIBH manoeuvre in prone position (chapter 7). 
This thesis confirms the benefits of prone positioning on lung sparing and target dose distri-
bution. Moreover, prone WBI results in a strong reduction of acute toxicity in large breasted 
patients. We demonstrated the feasibility of prone DIBH enabling to minimize heart dose 
metrics while preserving the advantages of prone positioning. Further refinement of prone 
DIBH is ongoing research. This thesis strengthens the evidence towards a paradigm shift, 
to replace the standard supine by prone WBI.
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SAMENVATTING
Borstkanker is de meest gediagnosticeerde kanker en de belangrijkste oorzaak van kanker- 
sterfte bij vrouwen. Radiotherapie (RT) na borstsparende heelkunde halveert de kans op 
herval en vermindert het risico op borstkankersterfte met ongeveer 20%. Toch neemt het 
bewijs toe dat borstbestraling wordt geassocieerd met belangrijke, zelfs lethale bijwer-
kingen. Borstbestraling is gerelateerd met hartziekte en kanker inductie, voornamelijk ter 
hoogte van de longen en heterolaterale borst. Het doel van dit proefschrift is om de be-
stralingstechniek te optimaliseren voor volledige borstbestraling door de risico-organen 
maximaal uit te sparen en een adequate homogene dosis te geven aan de volledige borst. 
Dit met speciale aandacht voor de klinische toepasbaarheid van nieuwe technieken en 
overdraagbaarheid naar andere centra. 
In de standaard ruglig positie spreidt de borst uit over de thoraxwand waarbij het hart en 
de longen worden omhuld. Dit leidt tot een suboptimale anatomie om een homogene dosis 
voor de borst te verkrijgen en om de dosis op de risico-organen te beperken. Buiklig biedt 
een aantal voordelen; het elongeert de borst weg van de intra-thoracale regio en het ver-
nauwt de borst terwijl de huidplooien verdwijnen. In het eerste deel van dit proefschrift is 
het ons doel om de bestralingstechniek in beide posities te optimaliseren. In ruglig bleek 
de meerdere bundels intensiteit gemoduleerde RT de beste techniek om een  conforme 
dosis te verkrijgen op de borst en om hart en longen uit te sparen. In buiklig bleek het 
effect van behandelingstechniek veel minder uitgesproken. Doch buiklig resulteerde in 
betere resultaten: een betere conformiteit van de bestraalde borst, superieure longdosis-
sen en een betere hartsparing voor alle patiënten met volumineuze borsten (hoofdstuk 3). 
Ons verder onderzoek focuste op het valideren van buiklig borstbestraling met aandacht 
voor linkszijdigen. 
Het tweede deel van dit proefschrift betreft een vergelijkende klinische beoordeling van de 
beste buik- en ruglig techniek. Van belang was de dagelijkse reproduceerbaarheid van de 
CT-gesimuleerde positie tijdens de behandeling. Dagelijkse cone beam CT (CBCT) was 
de gewenste techniek, doch de bestaande CBCT parameters werden niet geoptimaliseerd 
voor borstbestraling. Daarom werden de CBCT parameters aangepast om de oppervlakte- 
reconstructie en klinische toepasbaarheid te verbeteren en de stralingsbelasting te ver-
minderen (hoofdstuk 4).
Een gerandomiseerde gecontroleerde studie werd uitgevoerd waarin buik- met ruglig werd 
vergeleken bij 100 patiënten met volumineuze borsten. De studie bevestigt eerdere dosi-
metrische resultaten. Buiklig kon de dosis distributie binnen de borst en uitsparen van hart 
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en longen verbeteren. Buiklig is tevens geassocieerd met significant minder acute toxiciteit. 
Vochtige desquamatie werd teruggebracht van 20% in ruglig tot 6% in de buiklig cohorte. 
Dermatitis, oedeem en pijn waren minder frequent en minder ernstig in de buiklig groep. 
Deze studie geeft niveau-I bewijs voor het vervangen van ruglig door buiklig bij patiënten 
met volumineuze borsten (hoofdstuk 5).
In het derde deel van dit proefschrift hebben we ons gericht op het optimaliseren van de 
hartdosis in buiklig. Eerst hebben we onderzoek gedaan naar de effecten van diepe adem-
halingsblokkage, een techniek die met succes gebruikt wordt in ruglig, om de hartdosis 
te verlagen voor linkszijdige bestraling in buiklig. In silico analyse toonde aan dat diepe 
ademhalingsblokkage in buiklig de hartdosis beperkte met behoud van de voordelen van 
buiklig op longsparing (hoofdstuk 6). De reproduceerbaarheid van deze techniek werd 
bestudeerd in 30 patiënten. CT-simulatie en ademhalingsgegevens werden geanalyseerd, 
allen wijzend op de haalbaarheid en de goede reproduceerbaarheid van diepe adem- 
halingsblokkage in buiklig (hoofdstuk 7). 
Dit proefschrift bevestigt de voordelen van buiklig op long sparing en dosisverdeling binnen 
de borst. Bovendien zorgt het voor een sterke reductie van de acute toxiciteit bij patiën-
ten met volumineuze borsten. Tevens toonden we de klinische uitvoerbaarheid van diepe 
ademhalingsblokkage in buiklig aan; een techniek waarbij hartdosis wordt geminimaliseerd 
met behoud van de voordelen van buiklig. Verder onderzoek is lopende ter optimalisatie 
van deze nieuwe techniek. Dit proefschrift versterkt het bewijs voor een paradigmaver-
schuiving van de standaard ruglig naar buiklig voor volledige borstbestraling.
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CHAPTER 1: BACKGROUND 
1.1  ROLE OF RADIOTHERAPY IN BREAST CANCER 
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer 
death among females, accounting for 23% of total cancer cases and 14% of cancer deaths 
[1]. In 2010, 9908 Belgian women were newly diagnosed with breast cancer, which is ap-
proximately one third of newly diagnosed cancers in females [2]. For early stage breast can-
cer patients, breast-conserving surgery (BCS) followed by adjuvant whole breast irradiation 
(WBI) has replaced mastectomy as standard of care, since both treatments have shown to 
be equivalent in several randomized controlled trials [3-6]. The advantages of BCS include 
less invasive surgery with shorter recovery time and breast preservation, which is important 
for a women’s self image. However microscopic tumor foci might remain in the treated 
breast leading to locoregional recurrences and/or distant metastases. The role of adjuvant 
radiotherapy (RT) after breast sparing surgery is to eradicate these cancer deposits. 
The need of radiotherapy (RT) after BCS was clearly demonstrated by the “Early Breast 
Cancer Trialists’ Collaborative Group” [7, 8]. In the meta-analysis of 2005 [7] the 5-year 
risk of local recurrence was 7% among those allocated for RT versus 26% in the non-RT 
group, corresponding to an absolute risk reduction of 19%. An update in 2011 [8] based 
on 10081 patients showed that RT nearly halves the 10-year recurrence risk (absolute risk 
reduction = 16%), reduces the 15-year risk of breast cancer death with almost 20% (abso-
lute risk reduction = 4%) leading to a 15-year absolute overall survival benefit of 3%. For 
every four recurrences avoided by year 10, about one breast cancer death was avoided by 
year 15. This meta-analysis is based on patients irradiated between 1976 and 1999 and 
it is not clear whether these benefits can be translated to patients treated in more recent 
years with more contemporary systemic therapies. However, a recent retrospective trial 
performed by Wockel et al. [9] confirms the benefit of guideline-adherent adjuvant RT in 
patients treated between 1992 and 2008. 
These data provide level I evidence of adjuvant RT after BCS. Still WBI is associated with 
severe acute and late side effects to the treated breast and organs at risk (OARs).
 1.2  RADIOTHERAPY INDUCED SIDE EFFECTS: 
Breast RT was considered harmless; but evidence accumulates in recent years that RT 
correlates with severe, even lethal side effects. Long-term epidemiological data revealed 
that patients who received RT had an increased risk of non-breast cancer death especially 
9§ I .  BAC KGROU N D
due to cardiac events and secondary cancer induction [10-21]. Due to the increased 
awareness of these major complications of breast RT, research on prevention of radia-
tion-induced side effects has been intense and several entities including radiation tech-
niques, respiration-related RT and position alterations have been explored. In this chapter, 
examples of radiation-induced side effects are reported per organ (A) as well as possible 
strategies to reduce/prevent these effects (B).
1.2.1 Ipsilateral breast
A) Impaired cosmesis, fibrosis and skin changes 
Severe acute breast toxicity is reported in 40-50% of patients using standard techniques 
in supine position. Skin desquamation, dermatitis, edema, pruritus and pain to the treated 
breast are often reported during or shortly after breast RT [22-32]. These side effects have 
been shown to negatively influence physical, emotional and functional well-being, body 
image and treatment satisfaction, moreover to negatively affect quality of life (QOL) [27, 30]. 
Prolonged follow-up demonstrated RT-induced cosmetic alterations to the treated breast 
including breast fibrosis, skin atrophy, telangiectasia and pigmentation changes. Using 
photographic assessments, Donovan et al. [26] reported changes in breast appearance 
5 years after irradiation in 40-58% of patients depending on the used radiotherapy tech-
nique. Hopwood et al. [31] published that 4 out of 10 women report moderate to marked 
changes of the treated breast 5 years after completing their RT treatment using non- 
intensity modulated techniques. 
Acute and late breast toxicity has been related with target dose distribution parameters. 
Dose heterogeneity and the presence of high dose regions (hot spots) within the treated 
breast have been associated with breast toxicity [25-29]. Therefore it is warranted to 
obtain an optimal dose distribution covering the target volume while maximizing dose 
homogeneity. 
B) Radiation techniques and position alterations
The ability of traditionally used wedged tangential fields (W-TF) to provide a homogenous 
dose distribution is rather restricted due to the complex shape of the breast in supine 
position. Tangential field intensity modulated RT (TF-IMRT) has been introduced to improve 
target dose distribution and has translated in reduced breast toxicity as shown in random-
ized controlled trials [26-29]. Pignol et al. [27] performed a randomized multicenter, double- 
blind trial involving 358 patients treated either by IMRT or by W-TF. Moist desquamation 
occurred in 47.8% of the standard treatment group compared to 31.2% in the IMRT group; 
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resulting in a significant (p=0.002) absolute reduction of 16.6%. The presence of moist 
desquamation was associated with pain and a decreased QOL. Donovan et al. [26] used 
photographs to assess cosmesis and observed that W-TF are 1.7 times more likely to 
cause a change in breast appearance 5 year after breast irradiation compared to IMRT. 
A recent trial of Mukesh et al. [28] confirmed the superiority of IMRT techniques in terms 
of telangiectasia and cosmesis compared to conventional techniques.
The width and shape of the supine breast makes it difficult to obtain a homogeneous dose 
distribution in the target. Furthermore, skin folds like the axillary and inframammary fold 
prevent the skin-protective build-up region of photon beams. As shown in figure 1.1, prone 
position provides some theoretical advantages due to the gravity-induced anatomical 
changes: (1) it elongates the breast away from the intra-thoracic region and is therefore 
able to reduce intra-thoracic irradiation; (2) it narrows the breast enabling to reduce the 
radiological pathlenghts traversing the breast and (3) it opens the skin folds and is there-
fore able to restore build-up effect in this region [33-35]. 
 
Figure 1.1: Anatomical modification by executing prone (B) compared to supine (A) position. Prone position elon-
gates the breast away from the intra-thoracic region (marked with solid arrow), it narrows the breast 
and unfolds the skin folds (marked with dotted arrow).
1.2.2 Heterolateral breast
  A) Carcinogenesis 
After breast irradiation, an excess of 1.8% in contralateral breast cancer incidence has been 
reported over a period of 15 years in a meta-analysis of RT vs. non-RT trials for patients 
treated from the seventies till the nineties [15]. The risk of developing a second primary con-
tralateral breast cancer after breast RT is related to patient age, family history, obesity, alco-
hol, smoking, heterolateral breast dose, hormonal therapy and systemic therapy [15, 36-38].
A) Supine position. B) Prone position.
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  B) Radiation techniques
Current gantry beam angles are chosen in order to completely avoid heterolateral breast 
dose, though avoidance of the heterolateral breast might be at cost of an increased 
intra-thoracic dose. 
1.2.3 Lungs
  A) Carcinogenesis, inflammation and functional changes
Breast irradiation has been associated with acute, subacute and chronic side effects to 
the ipsilateral lung including pneumonitis and lung fibrosis. These iatrogenic effects are 
related to irradiated lung volume, lung dose, systemic therapy, chronic obstructive pulmo-
nary disease, smoking and age [39-43]. Figure 1.2 shows a RT-induced pneumonitis 
3 months after treatment and its relation to the dose distribution on the treatment plan.
Figure 1.2: Radiation-induced pneumonitis (B) after breast irradiation and its relation to the dose distribution (A). 
Patients irradiated in older breast cancer trials (treated between 1973 and 2008) showed 
an increased risk of mortality from lung cancer at the side of the irradiated breast with 
a rate ratio of 1.30 [10]. In the meta-analysis [15] published by the “Early Breast Cancer 
Trialist’s Collaborative Group; 3666 non-breast cancer deaths were reported, 156 died of 
lung cancer with a rate ratio of 1.78 for irradiated patients. The physiopathology or the dose/
volume relationship is not clear; though the available data suggest a linear association 
between dose and incidence of lung cancer without a threshold dose and no evidence of 
a downturn risk [44]. In a recent trial by Grantzua et al. [45] the risk rate of lung cancer 
increased linearly with 8.5% per Gy for non-smoking and 17.3% per Gy for smoking 
A) Patient treatment plan. The colored lines  
(isodoses) indicate the different dose levels in Gy.
B) Radiation induced pneumonitis  
(indicated with red arrow) 3 months after RT.
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patients. Still the absolute amount of lung cancer patients after breast RT remains low, in 
this cohort of 23627 early breast cancer patients treated from 1982 till 2007 only 187 cases 
were documented. Still vigilance is required since odds ratios of mortality from radiation 
induced lung cancer (ipsilateral versus contralateral) increase with time from treatment [10].
  B) Radiation techniques and position alterations
Multi-beam IMRT (MB-IMRT), tomotherapy and arc therapies are able to reduce high dose 
regions within the lung, though often at the expense of an increased low dose spread to 
heart, lungs and contralateral breast [46-51]. 
Prone as compared to supine position elongates the breast away frow the intra-thoracic 
region (as shown in figure 1.1) resulting in a spectacular decrease in lung dose. In the New 
York University trial [52], prone position was associated with a reduction of the in-field lung 
volume of 86% for right-sided patients and 91% for left-sided patients. This spectacular 
decrease in lung dose was consistently reported in trials in which individual comparative 
prone versus supine planning was made [35, 52-58].
1.2.4  Heart
  A) Cardiac disease
Heart disease after breast irradiation is well documented and of major concern [10-16, 
20]. Cardiac disease by radiation injury is caused by an interplay of inflammation, fibrosis 
and atherosclerosis especially due to micro- and macrovascular damage. Different types 
of heart disease by RT have been identified: (1) Myocardial infarction is a consequence of 
coronary artery sclerosis. (2) Congestive heart failure is mainly related with microvascular 
radiation injury causing interstitial myocardial fibrosis. (3) Valvular disease is also related 
with fibrotic changes. (4) Pericarditis is a result of an exudative inflammatory response. (5) 
Arrhythmias or conduction defects are related with ischemia or fibrosis to the sinus, the 
AV node or to the conduction system [20, 21, 59]. The trial of McGale et al. [14] involv-
ing 34825 women irradiated during 1976-2006 demonstrated increased left versus right- 
sided incidence ratios of 1.22 for acute myocardial infarction, 1.25 for angor, 1.54 for val-
vular heart disease and 1.61 for pericarditis. US Surveillance, Epidemiology and End 
Results (SEER) data [10] showed that cardiac mortality increases over time, moreover 
cardiac mortality ratios of left versus right-sided breast cancer patients irradiated during 
1973-1982 are 1.19 at <10 years, 1.35 at 10-14 years, 1.64 at 15-19 years and 1.90 at >20 
years; cardiac mortality was observed in 3117 of the 130285 left-sided compared to 2743 
of the 126691 right-sided irradiated patients. In unirradiated patients, the cardiac mortality 
risk was equal for left- and right-sided breast cancer. 
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The clinical dose/volume-effect relationship for radiation induced cardiac mortality is not 
entirely understood. It is most probably an interaction between dose and irradiated cardiac 
volume. Darby et al. [16] observed a linear relationship between mean heart dose and 
relative risk of ischemic heart disease starting within a few years and continuing decades 
after breast RT. Rates of major coronary events increased with 7.4% per Gy mean heart 
dose, with no apparent threshold dose. The left anterior descending coronary artery (LAD) 
is especially exposed by left-sided irradiation. Dose to the LAD is associated with coronary 
disease, leading to excess radiation-induced mortality after prolonged follow-up [14, 60, 61].
Data of more recently treated patients [10, 13, 62, 63] show a trend of a decrease of car-
diovascular disease, which can probably be attributed to adjusted treatment techniques, 
better positioning verification and modified target volume definitions. Still, it is well docu-
mented that modern treatment techniques cause cardiac injury [63-66] and recent data 
must be interpreted with caution because odds ratios of radiation-related cardiac mortality 
still increase after 20 years of follow-up [10]. 
  B) Radiation techniques, position alterations  
   and respiration-related RT
The ability of TF-IMRT compared to conventional techniques to reduce intra-thoracic irradi-
ation is rather limited. MB-IMRT, intensity modulated arc therapy and helical tomotherapy 
can reduce high dose regions to heart though often at cost of low or intermediate dose 
spread [46-51]. 
Prone position provides gravity-induced anatomical changes (cfr figure 1.1). It elongates 
the ipsilateral breast away from the intra-thoracic region, but it induces also an anterior 
shift of the heart; which could be detrimental for prone left-sided breast irradiation [67, 68]. 
Formenti et al. [52] scanned 400 patients in prone and supine position and made an indivi- 
dual dosimetric comparison. Prone position was able to reduce the in-field heart volume in 
85% of patients with significantly better LAD-sparing. Formenti et al. [52], Lymberis et al. 
[54] and Kirby et al. [53] correlated the benefit of prone position to breast-volume. Reduced 
heart doses are observed in all large-breasted patients treated in prone position, while for 
small breasted patients results are indistinct. 
Inspiration causes an increased distance between the heart/LAD and the irradiated anterior 
chest wall/breast region. In left-sided breast cancer patients these anatomical modifica-
tions are used to decrease heart and LAD dose by respiration-related methods. Voluntary 
deep inspiration breath hold (DIBH) is irradiation while the patient is in a deep inspiratory 
apnea phase and is performed in several cycles during treatment in supine position [69-
74]. Figure 1.3 demonstrates the increased breast-heart distance by performing DIBH 
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compared to normal or shallow breathing (SB). A planning comparison by Swanson et al. 
 [73] in 87 left-sided breast cancer patients found a relative mean heart dose reduction 
of 40% and a relative mean lung dose reduction of 13% with DIBH compared to SB in 
supine position. A more recent study of Nissen et al. [74] comparing 144 left-sided pa-
tients treated in DIBH with 83 patients in SB demonstrated a mean heart dose reduction 
of 48% in the DIBH cohort. 
It might be difficult to evaluate the benefit of modern treatment techniques on cardiac mor-
bidity or death since early stage breast cancer patients are long-term survivors and radia-
tion induced cardiac disease might occur several decades after breast RT [10]. Therefore it 
is warranted to have short-term surrogates of cardiac toxicity. Several methods have been 
developed including the strain rate imaging technique developed by the Leuven group [66] 
or single-photon emission CT scans [75]. 
Figure 1.3: Increased breast-heart distance by deep inspiration breath hold (B) compared to shallow breathing 
(A) in the supine position, based on the transversal slide of the nipple (red arrow). 
B) Deep inspiration breath hold.A) Shallow breathing.
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CHAPTER 2: OBJECTIVES
2.1 PURPOSE
This research includes improving radiation techniques, applying respiration-control meth-
ods and studying other patient positions than the standard supine. The unifying principle 
of this research is to provide a dose distribution which serves a dual goal: to achieve the 
intended therapeutic effect while avoiding side effects in the target volume as well as in 
the surrounding organs. 
The purpose of WBI:
1) Homogeneous prescription dose to the ipsilateral breast
  - securing therapeutic objectives
  - avoiding cosmetic changes, fibrosis and skin alterations
2) Avoiding irradiation of contralateral breast
3) Avoiding lung irradiation
4) Avoiding heart and LAD irradiation
2.2 STARTING POINT: What was realized at Ghent university  
 hospital before the onset of this thesis work?
A previous in-house study performed by Veldeman on supine WBI demonstrated the 
benefit of MB-IMRT on OARs-sparing compared to W-TF and TF-IMRT. Still the unique 
anatomical challenge of the breast target volume, medially flanked by the heterolateral 
breast and enwrapping heart and lungs, makes the goal of no primary beam dose to the 
OARs impossible to achieve with MB-IMRT alone. 
Figure 2.1.:  Beam setup for MB-IMRT, TF-IMRT and W-TF in the supine position, the beam gantry angles are 
  indicated with the green arrows.
W-TF & TF-IMRT 
2 opposing beams
MB-IMRT 
6 non-opposing beams
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Therefore an alternative approach by altering the patient’s position into prone position was 
performed and in silico assessment demonstrated the potential of prone position to per-
form a spectacular lung dose reduction and improve population characteristics for dose 
inhomogeneity [1, 2]. A routinely applicable prone IMRT technique was developed using a 
modified commercially available breast board and a unilateral breast holder to retract the 
heterolateral breast away from the treated zone [1]. Using this technique a setup precision 
comparable to supine position could be obtained not only by comparing with other supine 
cohorts [1] but also on an intra-patient based assessment [2]. Moreover, prone WBI was 
able to reduce respiration-related breast movement during treatment.
Daily reproducibility of the CT-simulated position during treatment is crucial. Patient- 
positioning errors are corrected for by rigid image co-registration between cone beam CT 
(CBCT) and planning CT. The CBCT parameters were yet improved [3], though not fully 
optimized for breast RT. 
2.3 OBJECTIVES OF THIS THESIS
The first objective of this thesis was to perform a comparative clinical assessment and vali-
dation of prone versus supine IMRT. This was done in a phase II trial randomizing patients 
with at least a cup size C between prone and supine IMRT (chapter 5). The primary end-
point was acute skin toxicity (moist desquamation). Secondary endpoints included dose/
volume parameters for lung, heart and contralateral breast to estimate long-term risk of 
cardiac insults, lung cancer and heterolateral breast cancer induction. Before initiation of 
the randomized trial, the best prone radiation technique to compare with supine MB-IMRT 
was identified (chapter 3). 
The second objective of this thesis was to enhance the clinical feasibility of prone WBI 
in view of implementation of the technique in daily routine. Therefore a number of issues 
had to be resolved. Optimization of the unilateral breast holder was done and a new 
breast board was constructed in collaboration with Orfit Industries (Wijnegem, Belgium) 
using their commercially available breast board as a starting point with the aim to improve 
patient comfort and setup reproducibility. The venue of a new linear accelerator at GUH 
with a more recent CBCT version, created the possibility to further improve the acquisi-
tion protocol regarding surface reconstruction, decrease radiation exposure and enhance 
clinical feasibility (chapter 4). 
The third objective of this thesis was to address the issue of heart sparing in prone posi-
tion. Patients with small cup size (A or B) were not included in the randomized trial for 2 
reasons. First, the risk of acute moist desquamation, the primary endpoint, is correlated 
with cup size with large-breasted patients being at higher risk. If small-breasted patients 
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were included the effect size was expected to be smaller and the sample size had to be in-
creased. The second reason was the fear of increased heart dose in prone position in small 
breasted patients. Cooperation with Vincent Remouchamps at CMSE Namur was start-
ed to investigate the possibility of combining prone position with DIBH to maximize heart 
sparing. The feasibility and reproducibility of prone DIBH is described in chapters 6 and 7.
2.4 REFERENCES 
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Radiat Oncol Biol Phys 2012;82:2055-2064.
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ABSTRACT
Background: Early stage breast cancer patients are long-term survivors and finding 
techniques that may lower acute and late radiotherapy-induced toxicity is crucial. We com-
pared dosimetry of wedged tangential fields (W-TF), tangential field intensity-modulated 
radiotherapy (TF-IMRT) and multi-beam IMRT (MB-IMRT) in prone and supine positions 
for whole-breast irradiation (WBI).
Methods: MB-IMRT, TF-IMRT and W-TF treatment plans in prone and supine positions 
were generated for 18 unselected breast cancer patients. The median prescription dose 
to the optimized planning target volume (PTV
optim) was 50 Gy in 25 fractions. Dose-volume 
parameters and indices of conformity were calculated for the PTV
optim and organs-at-risk.
Results: Prone MB-IMRT achieved (p<0.01) the best dose homogeneity compared to 
WTF in the prone position and WTF and MB-IMRT in the supine position. Prone IMRT 
scored better for all dose indices. MB-IMRT lowered lung and heart dose (p<0.05) in 
supine position, however the lowest ipsilateral lung doses (p<0.001) were in prone position. 
In left-sided breast cancer patients population averages for heart sparing by radiation dose 
was better in prone position; though non-significant. For patients with a PTV
optim volume 
≥600 cc heart dose was consistently lower in prone position; while for patients with smaller 
breasts heart dose metrics were comparable or worse compared to supine MB-IMRT. Doses 
to the contralateral breast were similar regardless of position or technique. Dosimetry of 
prone MB-IMRT and prone TF-IMRT differed slightly.
Conclusions: MB-IMRT is the treatment of choice in supine position. Prone IMRT is superior 
to any supine treatment for right-sided breast cancer patients and left-sided breast cancer 
patients with larger breasts by obtaining better conformity indices, target dose distribution 
and sparing of the organs-at-risk. The influence of treatment techniques in prone position 
is less pronounced; moreover dosimetric differences between TF-IMRT and MB-IMRT are 
rather small.
INTRODUCTION
Conventional radiotherapy (RT) using wedged tangential fields (W-TF) after breast-con-
serving surgery improves disease control and breast-cancer related survival. However pro-
longed follow-up showed an increased RT-induced risk of cardiac events and secondary 
lung and breast cancer in long-term survivors [1-3]. Therefore strategies for sparing organs-
at-risk (OARs), while maintaining an adequate dose coverage of the target are warranted.
In supine position the whole-breast clinical target volume (CTVWBI) is concave 1) enwrap-
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ping the lung and heart at the left side, and 2) medially adjoining the contralateral breast. 
Therefore parts of the ipsilateral lung, heart, and contralateral breast may receive inter-
mediate to high doses with W-TF.
Intensity-modulated radiotherapy (IMRT) can provide advantages compared to W-TF. In 
supine position IMRT using a tangential two-beam set-up (TF-IMRT) can improve dose 
homogeneity; however its ability to reduce high-dose regions to the underlying heart and 
lung tissue appear to be limited [4, 5]. Supine multi-beam IMRT (MB-IMRT) may overcome 
those limitations often at cost of low- or intermediate-dose spread over the contralateral 
breast and ipsilateral thoracic region [6-10].
Prone position modifies the target volume by gravity and moves the breast away from 
the chest wall. Prone W-TF has previously been used for large, pendulous breasts [11] to 
reduce fibrosis and improve cosmesis [12, 13]. There are a few studies reporting improved 
dosimetry by prone TF-IMRT [14-16], though data on whole-breast MB-IMRT in prone 
position are lacking. Moreover, all dosimetric studies comparing prone and supine position 
used only non-multi-beam techniques [16-20]. We performed the present study to estab-
lish the effect of treatment technique (W-TF, TF-IMRT or MB-IMRT) and position (prone or 
supine) on dose coverage and heart and lung sparing.
MATERIALS AND METHODS
Eighteen unselected early stage breast cancer patients - 6 right-sided and 12 left-sided 
 - presenting for whole-breast irradiation (WBI) without nodal irradiation after breast con-
serving surgery were included in this study, approved by the ethics committee of Ghent 
University Hospital. Three-mm thick computer-tomography scans were acquired with an 
Aquilion scanner (Toshiba Medical Systems, Tokyo, Japan) in all patients in prone and 
supine position. Patient set-up and delineation of the clinical and planning target volumes 
for WBI (CTVWBI and PTVWBI, respectively) and OARs in both treatment positions can be 
found elsewhere [16, 17].  Extension of the PTVWBI outside the skin into the air accounted 
for respiration-related breast movement or swelling of the breast during treatment. A flash 
region was created outside the patient’s external contour by expanding the PTVWBI with 
a 10 mm margin followed by subtraction of the patient’s total scanned volume. This flash 
region was subsequently used in the optimization. A planning target volume for optimiza-
tion (PTV
optim), a structure used during plan optimization, was generated by removing the 
in-air part and a 7 mm-wide build-up region underneath the skin from the PTVWBI.
The dosimetric comparison was made for 6 MV photon beams of an Elekta SLi18 linear ac-
celerator (Elekta, Crawley, UK) equipped with a standard 1 cm leaf-width multileaf collimator 
(MLC). A median prescription dose to the PTV
optim was 50 Gy in 25 fractions of 2.0 Gy with 
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the objective of ≥95% of the PTV
optim receiving >95% of the prescribed dose and minimi-
zation of maximum dose, dose heterogeneity and “hot spots”. In both positions TF-IMRT 
used the same gantry angles as W-TF with the collimator set at 0° and the beams shaped 
around the PTVWBI with the aid of the MLC. Figure 1 shows the 6-beam setup used in the 
MB-IMRT plans for right-sided breast tumors in supine position (a) and prone position (b). 
In both positions MB-IMRT used 6 coplanar beams shaped around the PTVWBI and as in 
TF-IMRT plans field-in-field segments were created avoiding the ipsilateral lung, heart 
(in case of left-sided breast tumors) and contralateral breast (for lateral beams in supine 
position, since medial beams did not traverse the contralateral breast).
Figure 1.: Multi-beam set-up in the prone and supine position. A 6-beam set-up used in the multi-beam intensi-
ty-modulated radiotherapy (MB-IMRT) plans for right-sided breast tumors in supine (a) and prone posi-
tion (b). Gantry angles expressed in the Elekta coordinate system. The most inclined medial beam has 
the gantry angle of a tangential beam set by virtual simulation [21]. The gantry angles are 0°, |α|, |2α|, 
180° - 0.5|β|, 180° + 0.5|β|, and 180° + 1.5|β| for supine MB-IMRT. The lateral gantry angles in prone 
MB-IMRT are |β|, |β|+/−24°, the medial gantry angles are |α|, |α|+/− 12°.
A forward planning approach was used for the intensity-modulated and W-TF plans. The 
convolution-superposition dose engine of a Pinnacle version 9.0 treatment planning sys-
tem (Philips Medical Systems, Andover, US) was used for dose computations between 
optimization cycles of intensity-modulated plans as well as for final plans. Monitor units and 
MLC shapes were optimized using the optimization tools described before [22]. During op-
timization, two patient geometries were taken into account: 1) dose computation for PTVWBI 
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was performed using a density override (1 g/cm3) to the above-mentioned flash region; 2) 
dose computation for the PTVWBI without build-up and OARs was performed without density 
overrides. To be able to compute both dose distributions in parallel, the patient data at the 
Pinnacle treatment planning system were duplicated: for the first patient dataset the flash 
region was set water-equivalent, while for the second patient dataset, the flash region 
remained at the density of the CT data (in essence, air outside the patient outline). To avoid 
hot spots outside regions of interest, a “matroska” sequence of shell structures (isotropical 
expanded structures outside the target volume) [22] was generated outside the PTVWBI, 
which were taken into account during optimization. Dose computation for these shell struc-
tures was performed using the above-mentioned density override in the flash region. Also 
the dose update mechanism for changes in leaf positions during optimization took both 
patient geometries into account. This method was used mainly to account for substantial 
deformations of the breast during the course of treatments.
D2 and D98, or the dose exceeding 2% and 98% of the dose-volume histogram (DVH) 
points, respectively, were used as surrogates for maximum and minimum dose. These were 
evaluated for the PTV
optim, as well as dose homogeneity (1-(D2-D98/median dose)). For the 
heart and ipsilateral lung D2, mean dose (Dmean), V5, V10, V20 and V25 or the proportion of 
the volume receiving at least 5 Gy, 10 Gy, 20 Gy and 25Gy, respectively, were extracted 
from the DVH data. For the contralateral breast D2 and Dmean were evaluated.
The following indices were also calculated for the PTV
optim:
Jaccard index = A B / A B 
Where A is the volume covered by the PTV
optim and B is the volume covered by the 95% 
isodose, i.e., the volume receiving 47.5 Gy or more. The Jaccard index increases with 
increase in similarity or overlap between the target volume and the 95% isodose and is a 
measure of dose conformity of the treatment plan.
Dose-coverage index = A∩B1 / A
Where B1 is the volume covered by the 95-107% isodose, i.e. the volume receiving 
between 47.5 Gy and 53.5 Gy. The dose-coverage index calculates the proportion of the 
target, in which the treatment-planning objectives for the target are met. 
Mismatch index = B2 / B 
Where B2 is the volume covered by the 95% isodose and lying outside the PTV
optim. 
It is the fraction of the 95% isodose non-overlapping the target. If the mismatch index is 
large, large amounts of normal tissues receive 95% of the prescription dose, i.e., 47.5 Gy. 
One-way analysis of variance (ANOVA) was used for a pairwise comparison of dose-volume 
parameters and indices between MB-IMRT, TF-IMRT and W-TF in the 2 treatment positions. 
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RESULTS
One hundred-and-eight plans were generated. Figure 2 illustrates typical dose distributions 
obtained with the 3 techniques in prone and supine position.
Figure 2.:  Isodose distributions (in Gy) of the 6 treatment plans for a left-sided patient in a transverse plane. 
Abbreviations: W-TF = wedged tangential fields; TF-IMRT = tangential field intensity-modulated radio-
therapy; MB-IMRT = multi-beam intensity-modulated radiotherapy.
31
§ 3.  PU BL ICAT ION 1
Dose homogeneity and dose coverage of the target
Table 1 provides numerical data on target coverage and target dose distribution obtained 
with the 3 techniques in the prone and supine position. D2 is lowered in prone position 
resulting in improved dose homogeneity since D98 was similar for both positions. Signifi-
cance was obtained for prone MB-IMRT versus all supine techniques and a trend (p=0.05) 
for prone TF-IMRT compared to supine W-TF regarding D2; moreover prone MB-IMRT 
obtained better (p<0.01) dose homogeneity compared to supine W-TF and MB-IMRT. 
Intensity-modulated techniques were able to improve dose homogeneity compared to con-
ventional techniques in both positions, though significance (p=0.002) was only gained for 
prone MB-IMRT versus prone W-TF.  
Prone WBI scored better for Jaccard and mismatch indices (Table 1). Prone MB-IM-
RT achieved better results than any supine treatment technique (p≤0.03, both indices); 
followed by prone TF-IMRT versus supine TF-IMRT and W-TF (p≤0.001, both indices). 
In supine position MB-IMRT (p<0.001) was the best and W-TF (p<0.001) was the worst 
technique for both indices. Prone IMRT improved significantly (p<0.01) dose coverage 
index: prone TF-IMRT vs. supine MB-IMRT and prone MB-IMRT vs. supine MB-IMRT and 
TF-IMRT.
Technique D2 [Gy] D98 [Gy] Dose homogeneity [%]
prone supine prone supine prone supine
mean SEM SD mean SEM SD mean SEM SD mean SEM SD mean SEM SD Mean SEM SD
W-TF 52.3 0.1 0.6 53.1 0.2 0.9 47.6 <0.1 0.1 47.9 <0.1 0.4 90.6 0.3 1.1 89.7 0.5 2.1
TF-IMRT 52.0 0.2 0.8 52.6 0.2 0.8 47.8 <0.1 0.3 47.9 0.1 0.5 91.8 0.4 1.7 90.7 0.5 2.3
MB-IMRT 51.6 0.2 0.7 52.6 0.1 0.6 47.9 <0.1 0.2 47.7 <0.1 0.2 92.5 0.3 1.4 90.3 0.3 1.2
Table 1.a: Dose-volume parameters for the optimized planning target volume (PTV
optim).
Abbreviations:  SEM = standard error of the mean; SD = standard deviation; W-TF = wedged tangential fields; 
TF-IMRT = tangential field intensity-modulated radiotherapy; MB-IMRT = multi-beam intensity- 
modulated radiotherapy.
 
Technique Jaccard index [%] Dose-coverage index [%] Mismatch index [%]
prone supine prone supine prone supine
mean SEM SD mean SEM SD mean SEM SD mean SEM SD mean SEM SD mean SEM SD
W-TF 74.9 2.0 8.5 52.9 3.6 15.2 97.2 0.2 1.0 96.2 0.6 2.4 23.9 2.0 8.6 46.8 3.6 15.4
TF-IMRT 74.8 1.5 6.2 64.6 2.1 8.9 97.7 0.2 0.8 96.6 0.3 1.2 24.4 1.5 6.4 34.7 2.1 9.1
MB-IMRT 77.1 1.4 5.9 70.5 1.6 6.7 97.8 0.1 0.6 96.5 0.2 1.0 22.1 1.4 6.0 28.5 1.6 6.8
Table 1.b: Conformity indices for the optimized planning target volume (PTV
optim).
Abbreviations: SEM = standard error of the mean; SD = standard deviation; W-TF = wedged tangential fields; 
TF-IMRT = tangential field intensity-modulated radiotherapy; MB-IMRT = multi-beam intensity- 
modulated radiotherapy.
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Dose-volume parameters in OARs
Figure 3 illustrates cumulative DVHs of the ipsilateral lung (A, all patients) and heart (B, 
only left-sided patients), numerical data are presented in table 2. Sparing (p<0.001) of the 
ipsilateral lung by radiation dose was always superior in prone. There was little difference 
in ipsilateral lung dose between the 3 techniques in prone position, although V10 and V20 
were significantly lower in prone MB-IMRT vs. prone W-TF. In supine position treatment 
technique did alter lung dose (p<0.05), MB-IMRT achieved the best and W-TF the worst 
lung avoidance by radiation dose. A remarking feature is the modified (p=0.003) ipsilateral 
lung volume in both positions. Mean ± standard deviation for ipsilateral lung volume is 1504 
± 401cc for prone position versus 1409 ± 431cc for supine position.
Figure 3 A.: Cumulative dose-volume histograms of the ipsilateral lung. Abbreviations: W-TF = wedged tangential 
fields, TF-IMRT = tangential field intensity-modulated radiotherapy, MB-IMRT = multi-beam intensi-
ty-modulated radiotherapy.
 Heart dose was lowered with MB-IMRT compared to TF-IMRT (D2, Dmean, V5; p=0.07, 0.05 
and 0.03, respectively) and W-TF (D2, V5, p= 0.009 and 0.07, respectively) in supine po-
sition. While in prone position the effect of treatment technique on heart dose is less pro-
nounced. Population averages for heart dose metrics were non-significantly lowered in 
prone compared to supine position. Better heart sparing by radiation dose was consistently 
obtained in prone position for patients with a PTV
optim volume ≥600cc. While for patients 
with a PTV
optim volume <600cc heart dose metrics were comparable (2/5 patients) or worse 
(3/5 patients) in prone position compared to supine MB-IMRT.
Neither treatment technique, nor set-up significantly changed doses in the contralateral 
breast, all procedures achieved a maximum dose <5Gy and mean dose <1.5Gy for all 
patients. 
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Figure 3 B.:  Cumulative dose-volume histograms of the heart (only left-sided patients). Abbreviations: W-TF = 
wedged tangential fields, TF-IMRT = tangential field intensity-modulated radiotherapy, MB-IMRT = 
multi-beam intensity-modulated radiotherapy.
Technique Ipsilateral lung Heart
D
mean
 [Gy] V20 [%] V25 [%] Dmean [Gy] V20 [%] V25 [%]
prone supine prone supine prone supine prone supine prone supine prone supine
W-TF 1.2±0.6 7.7±4.5 0.9±1.0 13.5±10.2 0.7±0.8 12.1±9.3 1.9±1.1 3.9±3.4 1.2±0.6 4.9±1.9 0.8±1.7 4.0±5.8
TF-IMRT 1.1±0.5 5.7±3.1 0.5±0.7 9.8±7.0 0.3±0.5 8.5±6.4 1.6±0.5 3.3±2.5 0.4±0.2 3.4±1.4 0.3±0.6 2.9±4.3
MB-IMRT 0.9±0.4 5.1±2.6 0.2±0.4 7.6±6.2 0.1±0.3 6.4±5.5 1.6±0.4 2.5±1.7 0.3±0.1 1.9±0.9 0.2±0.3 1.4±2.2
  
Table 2.: Mean ± standard deviation for ipsilateral lung (all patients) and heart (left-sided breast cancer patients) 
dose metrics.
Abbreviations:  D
mean
 = mean dose; V20 and V25= partial volume receiving at least 20 Gy and 25 Gy, respectively; 
W-TF = wedged tangential fields; TF-IMRT = tangential field intensity-modulated radiotherapy; 
MB-IMRT = multi-beam intensity-modulated radiotherapy.
DISCUSSION
In supine position IMRT techniques obtain a higher Jaccard index, i.e. superior dose con-
formity, and less mismatch compared to W-TF with MB-IMRT being the superior technique 
for both indices. Dose conformity, coverage and mismatch are even better for the prone 
techniques, becoming statistically significant in prone IMRT plans. This is not surprising, 
since prone position results in a less concave breast volume. Therefore dose to the axil-
lary and shoulder region is substantially reduced and less of the prescription dose can be 
expected to be out of the target. Our results confirm the reduction of dose inhomogeneity, 
with IMRT-techniques compared to standard W-TF. Though differences were rather small 
and non-significant in supine position, which could be explained by the use of non-mixture 
beam energies. Prone as compared to supine IMRT does improve dose homogeneity and 
hot spots with the best results in prone MB-IMRT plans. Our results are in agreement with 
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other publications on prone IMRT. Goodman et al. [15] demonstrated a maximum dose in 
the target exceeding 110% with prone W-TF in 16 of 20 patients as compared to 1 patient 
with prone IMRT (TF-IMRT). Another study comparing MB-IMRT, TF-IMRT and 3D-CRT 
treatment plans of 5 patients planned in prone position reported significantly higher dose 
homogeneity of MB-IMRT plans vs. TF-IMRT (p=0.003) and 3D-CRT plans (p=0.03) [23]. 
Hardee et al. [14] observed a maximum dose reduction and improved median dose homo-
geneity in a prone TF-IMRT vs. 3D-CRT patient cohort. Moreover a 11%-decrease of grade 
2 dermatitis and a 16%-reduction of grade ≥2 hyperpigmentation were found in the IMRT 
group. We expect that improved dose homogeneity and hot spots achieved by prone IMRT 
– either MB-IMRT or TF-IMRT - will yield lower skin toxicity and better cosmesis [4, 5, 24].
Lung irradiation was lowered with the MB-IMRT technique in supine position, though spar-
ing of the ipsilateral lung appeared to be depending more on the treatment position than 
on the treatment technique. Prone position resulted in a spectacular decrease in lung dose, 
which is in coherence with other data [16-20]. The decrease in lung dose in prone position 
might also be attributed by the 7% increase in ipsilateral lung volume, for which we don’t 
have an explanation. All prone treatment techniques showed similar lung dose metrics.
Left-sided breast cancer patients are at risk of radiation-induced cardiac events [2], 
emphasizing the importance of using more sophisticated techniques to lower the heart 
dose. In supine position, MB-IMRT is able to lower the heart dose compared to the other 
techniques as shown both in our data and in other publications [7-9]. In prone position dif-
ferent treatment techniques have less effect on heart dose, especially between IMRT-tech-
niques. Even with MB-IMRT, only the minority of patients (3/12) benefitted from supine 
position; which is in coherence with other data [18, 20]. Moreover consistent better heart 
dose metrics were achieved in prone position for patients with a PTV
optim volume of ≥600cc. 
A limitation of this study is the absence of dose parameters of the left descending coronary 
artery, since this is likely associated with increased cardiac mortality.
The introduction of supine MB-IMRT was not successful because of its complexity, increase 
in dose to the contralateral breast and higher integral dose [7-9]. In contrast with these 
studies we selected beams that avoided the contralateral breast and removed beams that 
included too much lung tissue. In this way reducing the dose in the ipsilateral lung with 
MB-IMRT, both in supine and prone position, was not at cost of low-dose spread over the 
lung or heart as illustrated by the DVHs (Figure 3). The dose to the contralateral breast 
was not increased with MB-IMRT either, moreover a maximum dose <5Gy and mean dose 
<1.5Gy was obtained for all patients. 
As a consequence of the reduced ipsilateral lung and heart dose, better dose distribution 
and dose coverage, prone IMRT is superior to any supine technique for left-sided
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patients with larger breasts (PTV
optim≥600cc) and all right-sided patients. While for left- 
sided patients with smaller breasts individual comparative planning should be made be-
tween supine MB-IMRT and prone IMRT in order to choose the best technique for clinical 
execution. The dosimetric differences between prone TF-IMRT and prone MB-IMRT are 
rather small. Whether these “small” dosimetric benefits would cause a clinical benefit is 
unknown. The more complex and time consuming planning procedure and beam delivery 
of prone MB-IMRT should also be considered.
CONCLUSIONS
MB-IMRT is the preferred technique in supine position by providing better coverage indices 
of the target and sparing of organs-at-risk. However, prone IMRT is superior to any supine 
technique for right-sided breast cancer patients and left-sided breast cancer patients with 
larger breasts. The impact of treatment techniques in prone position is less prominent; 
moreover dosimetric differences between both IMRT-techniques are rather small.
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ABSTRACT
Background: Cone-beam computerized tomography (CBCT) enables three-dimensional 
information of the scanned region and provides soft tissue images with good spatial resolu- 
tion. Our aim was to optimize image acquisition settings for prone and supine breast radio- 
therapy with respect to contour accuracy, clinical practicalities, and radiation dose.
Methods: CBCT images were acquired for both prone and supine anthropomorphic phan-
toms and a female cadaver in supine and prone set-up. CBCT protocols were investigated 
by altering the tube current, exposure time, range of projection views, field of view (FOV), 
and starting angle. For clinical practicalities, the frequency of the use of an offset CBCT 
isocenter was evaluated at 558 205°-CBCTs (37 patients; 13 prone and 24 supine) and 
1272 360°-CBCTs (102 patients; 13 prone and 89 supine).
Results: Prone and supine breast CBCT images acquired with a bowtie filter, a small FOV, 
a range of projection views equaling 180°, a tube current of 20 mA and an exposure time 
of 32 ms, demonstrated adequate contour accuracy and an elimination of the offset CBCT 
isocenter procedure, while this occurred in 40.7% for the old full-rotation protocol. Further-
more a 4.3-fold dose reduction was observed for the Computed Tomography Dose Index 
(CTDIw) compared to the preset Chest M20 protocol.
Conclusion: The established 180° protocol demonstrated acceptable contour accuracy, 
eliminated the CBCT isocenter offset procedure and reduced patient radiation exposure.
ZUSAMMENFASSUNG
Hintergrund und Zielsetzung: Die Cone-beam-Computertomographie (CBCT) ermöglicht 
3-dimensionale Informationen der gescannten Region und CT-Bilder von Weichteilgewebe 
in guter räumlicher Auflösung. Unsere Zielsetzung war die Optimierung der Bildakquise für 
die Einstellungen bei Brustbestrahlungen in Bauch- und Rückenlage in Bezug auf Kontrast, 
Praktikabilität und Strahlendosis.
Patienten und Methodik: CBCT-Bilder wurden mit einem anthropomorphen Phantom 
und an einer weiblichen Leiche in Rücken- und Bauchlage aufgenommen. Verschiedene 
CBCT-Protokolle mit unterschiedlichem Röhrenstrom, unterschiedlichen Expositionszeiten, 
Projektionsbereichen, Bildausschnitten (FOV) und Anfangswinkeln wurden untersucht. Für 
die klinische Praxis wurde die Häufigkeit von erforderlichen CBCT-Isozentrum-Anpassun-
gen anhand von 558 205°-CBCT (37 Patienten; 13 in Bauchlage, 24 in Rückenlage) und 
1272 360°-CBCT (102 Patienten; 13 in Bauchlage, 89 in Rückenlage) überprüft.
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Ergebnisse: Die mit einem Bowtie-Filter, kleinem FOV, einer 180°-Rotation, 20 mA 
Röhrenstrom und einer Belichtungszeit von 32 ms erhaltenen CBCT-Bilder in Bauch- und 
Rückenlage gewährleisteten eine adäquate Konturgenauigkeit und vermeiden eine CBCT 
in Isozentrumsposition, die bei 40,7% in den alten Vollrotationsprotokollen erforderlich war. 
Weiterhin ergab sich eine 4,3-fache Reduktion des Computered-Tomography-Dose-Index 
(CTDIw) verglichen mit dem Chest-M20-Standard-Protokoll.
Schlussfolgerungen: Das 180°-Protokoll zeigt eine akzeptable Konturierungsgenauigkeit, 
vermeidet CBCT in Isozentrum-Position und reduziert die Strahlenbelastung für die 
Patientin.
INTRODUCTION
Cone-beam computerized tomography (CBCT) is used in daily practice for setup correction 
in multiple radiotherapy domains, including prone and supine breast radiotherapy [1-6]. 
Patient-positioning errors are corrected for by rigid image co-registration between daily 
CBCT and planning CT. CBCT provides three-dimensional (3D) information of the scanned 
region and provides soft tissue images with good spatial resolution, both potentially in-
creasing the geometric accuracy of radiotherapy delivery [7-10]. However, it is also a more 
complex and time-consuming imaging modality and the additional radiation exposure might 
increase the risk of secondary cancer [11].
Due to the absence of distinct anatomical features in breast tissue, the CBCT to planning 
CT alignment mainly relies on the breast contours, chest wall and, if present, surgical 
clips. In this respect, a previous study demonstrated the breast contours on CBCT image 
sets, acquired with the clinically standard settings, to be affected by multiple artefacts [12]. 
These contour inaccuracies were ascribed to reconstruction artefacts and panel satura-
tion effects. Lowering the CBCT tube current and exposure time eliminated this artefact. 
However, one of the limitations of the above-mentioned study was the absence of a bowtie 
filter [12]. This filter has been described to improve general image quality and reduce panel 
saturation effects [13]. Consequently, it has now become the new standard in CBCT 
imaging. Furthermore, this study only included full-rotation protocols, which are found to 
be challenging in clinical practice. In order to avoid collisions, a 10 cm translation of the 
patient in the ipsilateral direction (offset position) was often necessary prior to and after 
imaging. This intervention complicates procedures and increases treatment times. An-
other limitation was the use of polystyrene phantoms, as the described artefacts strongly 
depend on patient geometry.
In this study, the contour accuracy investigation is expanded to CBCT imaging with bowtie 
filtration. Moreover, we now investigate CBCT protocols using a limited range of projection 
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views up to 205°. This configuration is intended to eliminate the ipsilateral patient transla-
tion, as well as reducing both the imaging time and radiation dose to the patient [14]. For 
clinical relevance, evaluation was not only performed on polystyrene phantoms, but also 
on a human cadaver. Additionally, absorbed dose measurements were performed for all 
investigated protocols.
MATERIALS AND METHODS
Planning CT and CBCT images were acquired for both prone and supine anthropomor-
phic phantoms and a female cadaver in supine and prone set-up. As the polystyrene phan-
toms provided an excellent geometric stability, they allowed for the detection of very small 
volumetric discrepancies. The female cadaver, on the other hand, served as a clinically 
relevant model.
In this study, a Thiel cadaver was used since the Thiel embalming technique authentically 
preserves the different tissue layers (skin, subcutaneous fat and collagen tissue, fascia, 
muscular, visceral and glandular tissue) and keeps the complete range-of-motion of all 
joints intact, allowing for a precise setup (arrangement) of the body’s posture in accord-
ance with the corresponding clinical treatment position [15, 16]. The use of the cadaver 
was approved by the local ethics committee. An extensive description of the prone and 
supine thoracic phantoms (Polystyrol 495F, BASF, Germany, ρ=1.02 g/cm³)  has already 
been published [12]. Prone cadaver positioning was accomplished using a prone–lateral 
breast board (Orfit Industries, Wijnegem, Belgium). Supine cadaver set-up was supported 
by a supine arm support tool (Civco Medical Solutions, Orange City, IA, USA). The polysty- 
rene phantoms and cadaver were equipped with four and five titanium surgical clips 
respectively. These clips were positioned in three different planes in the central breast 
region. Image acquisition was performed for the left breast in all cases.
Helical planning CT images of the phantoms and the cadaver were acquired on a Toshiba 
Aquillion CT scanner (Toshiba Medical Systems, Tokyo, Japan) with a slice thickness of 2 
mm, a tube potential of 120 kVp and a tube current of 150 mA. Set-up reproducibility was 
optimized by marking the laser line positions on the phantoms and the cadaver.
Cone-beam CT acquisition was performed on the Elekta XVI CBCT imaging module of an 
Elekta Synergy linear accelerator (Elekta, Crawley, West-Sussex, UK). This module utilizes 
a flat panel imager consisting of an amorphous silicon detector and fluorescent screen 
(Perkin-Elmer, Waltham, MA, USA). An aluminum bowtie filter (Elekta, Filter Cassette 
Assembly, F1) can be mounted below the collimator. This filter modulates the X-ray flux at 
the skin–air interface and thus reduces panel saturation effects [13]. Image reconstruction in 
the accompanying XVI software (version 4.5.) is based on the Feldkamp–Davis–Kress (FDK) 
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cone-beam algorithm. An accurate set-up of the phantoms and cadaver was obtained by 
aligning the planning CT surface markings with the treatment room lasers.
Multiple CBCT protocols with varying mAs, range of projection views and starting angle 
were studied. A bowtie filter, an angular projection density of 1.85 and a tube potential 
of 120 kVp was used in all imaging protocols. As the maximum range of projection views 
amounted to only 205°, all protocols employed a small field of view (FOV) with a recon-
struction diameter of 270 mm. Preliminary research demonstrated extremely poor image 
quality using a medium FOV (reconstruction diameter 410 mm) for a limited range of 
projection views. As the medium FOV set-up is obtained by asymmetrically collimating 
the beam and shifting the detector panel in the corresponding direction, each projection 
view only partly samples the reconstructed FOV. Consequently, any reduction in range of 
projection views using a medium FOV results in severely affected image quality.
Firstly, contour accuracy was investigated for CBCT protocols using a varying tube cur-
rent and exposure time (40 mA–40 ms, 20 mA–32 ms and 20 mA–25 ms) while keeping 
the range of projection views constant (i.e. 205°). The X-ray source rotation started at 110 
and 70° for the prone and supine set-up respectively. The initial tube current and expo-
sure time values (40 mA–40 ms) are taken from the preset protocols using a bowtie filter. 
Whereas these preset bowtie filtration protocols always employ a medium FOV, they have 
now been adopted as a starting point for the small FOV investigation. Secondly, we as-
sessed the influence of a reduction in range of projection views (200, 180, 160 and 140°) 
and the X-ray source starting angle. The decrease in ranges was equally spread over the 
start- and endpoint of the original range. This means that the central angle was kept at the 
same physical location. This resulted in different starting angles for the different ranges. 
This evaluation was only performed for CBCT protocols using tube current and exposure 
time of 20 mA and 32 ms.
For all protocols, the conformity of planning CT and CBCT breast contours was visually 
inspected on the phantom and cadaver images in the XVI viewing and registration soft-
ware (version 4.5, Elekta, Crawley, West-Sussex, UK). Registration of CBCT to planning 
CT images was manually performed on the surgical clips and, for the female cadaver, the 
chest wall. As in clinical practice, all images were visualized using the soft window settings.
Computed Tomography Dose Index (CTDI) measurements were performed to estimate the 
influence of various CBCT acquisition settings (field of view, tube current and exposure 
time and angular range of projection views) on patient radiation dose. Measurements were 
performed using an Unfors XI Platinum CT detector (100 mm long pencil beam CT-ioniza-
tion chamber, type 146358, Unfors Instruments AB, Billdal, Sweden) in a cylindrical CTDI 
phantom (PMMA, diameter 32 cm, length 15 cm). In order to provide scattered dose along 
the complete CBCT field width, the phantom’s length was increased by adding at least 
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15 cm of polystyrene slabs (Polystyrol 495F, BASF, Germany, ρ=1.02 g/cm³) at the phan-
tom’s superior and inferior side. The phantom center was positioned in the imaging module 
isocenter. CTDI measurements were performed at the center and four equally distributed 
peripheral positions in the phantom (at 0, 90, 180 and 270°, distance to the center 10 
cm). For all CBCT protocols, the bisecting line of the range of projection views was always 
centered at 0°. The weighted CTDI (CTDIw) was then computed as (Elekta: XVI R4.5):
CTDIw= 
1_
3
 (CTDI
100,center
) + 2_
3 
(1_
4 ΣCTDI100,peripheral) 
In order to investigate the need for patient offset positioning, the frequency of this inter-
vention was compared between the old full-rotation protocol and a 205°-rotation proto-
col. To that purpose, 558 205°-CBCTs (37 patients; 13 prone and 24 supine) and 1272 
360°-CBCTs (102 patients; 13 prone and 89 supine) were included. The 205° protocol 
employs the maximum range of projection views employed in this investigation. As all 
further reductions in range of projection views were equally spread over the start- and 
endpoint of the original range, this 205° protocol served as the most critical protocol with 
respect to possible collisions.
RESULTS
This study investigated contour accuracy, radiation dose and the need for offset patient 
positioning for CBCT protocols using bowtie filtration, a small FOV and a limited range of 
projection views.
Firstly, we evaluated the dependence of contour accuracy on CBCT tube current and expo-
sure time for CBCT acquisitions using a bowtie filter, a small FOV and a range of projection 
views equaling 205° (Figure 1 a, b). The images represent a transversal slice through the 
center of the breast. Prone and supine CBCT phantom and cadaver images acquired with a 
tube current and exposure time of 40 mA and 40 ms, demonstrated an important periareolar 
tissue deficit (Figure 1 a, marked with dotted lines). An additional tissue deficit in the lateral 
region of the breast was detected in the supine CBCT images. As in the previous study, 
these CBCT contour inaccuracies were completely eliminated by lowering the tube current 
and exposure time to 20 mA and 32 ms (Figure 1 b, marked with dotted lines). The cranio- 
caudal tissue excesses, as detected in the previous phantom study, were still apparent 
in the polystyrene phantoms, but were hardly detectable in the female cadaver images.
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Figure 1.:  Dependence of contour accuracy on the CBCT tube current and exposure time (a, b). The correspond-
ing planning CT contours, automatically generated by the treatment planning system, are shown as 
solid red lines. The areas of interest showing the absence or presence of the artefacts are marked 
using dotted lines. The phantom images were acquired using a bowtie filter, a range of projection 
views of 205° and a tube current and exposure time equaling 40 mA–40 ms (a) and 20 mA–32 ms (b).
Secondly, the influence of a further reduction in range of projection views and the X-ray 
source starting angle was investigated for CBCT protocols using a tube current and 
exposure time of 20 mA and 32 ms respectively. This evaluation was uniquely performed 
on the female cadaver’s images (Figure 2). Contour accuracy was found to be adequate for 
protocols using a range of projection views equaling 180° or higher (Figure 2 I , II). When 
further reducing the angular range of projection views, several image artefacts affected 
the breast contour in itself, as well as the contrast of the matching features (i.e. the chest 
wall and surgical clips), thus compromising rigid registration.
The corresponding results of the CTDIw measurements are illustrated in Table 1. As can 
be seen, switching from a medium FOV to a small FOV for a given protocol generally in-
creases the CTDIw
 
(by 3.4 % and 1.4% for a full-rotation acquisition with a tube current 
and exposure time of 40mA - 40 ms and 20 mA - 32 ms respectively). However, in contrast 
to the asymmetrical M20 acquisition, the S20 set-up never uses a 360° acquisition, as this 
would oversample the projections. Consequently, the concomitant reduction in range of 
projection views strongly reduces the measured CTDIw: for a tube current and exposure 
time of 20 mA and 32 ms, the CTDIw of a 205°-S20 protocol amounted to only 66.3 % of 
the full-rotation M20 acquisition. As expected, lowering the mAs settings proportionally 
decreases the CTDIw. The applied 2.5-fold reduction (from 40 mA–40 ms to 20 mA–32 ms) 
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resulted in a 2.5-fold CTDIw decrease (26.8 mGy versus 10.6 mGy). Combination of a 180° 
rotation, use of small FOV, 20 mA, 32 ms, with use of bowtie filter results in a 4.3-fold dose 
reduction in CTDIw compared with the preset Chest M20 protocol. 
 
Figure 2.:  Dependence of contour accuracy on the CBCT range of projection views. The corresponding planning 
CT contours, automatically generated by the treatment planning system, are shown as solid red lines. 
The areas of interest showing the absence or presence of the artefacts are marked using dotted lines. 
The cadaver images settings comprised a tube current and exposure time of 20 mA–32 ms and a 
range of projection views of 200° (I), 180° (II), 160° (III) and 140° (IV).
Filtration Field of view Tube current  (mA)
Exposure time  
(ms)
Range of projec-
tion views (°) CTDIw (mGy)
F1 M20 40 40 360 23.4
F1 S20 40 40 360 26.8
F1 M20 20 32 360 9.2
F1 S20 20 32 360 10.6
F1 S20 20 32 205 6.1
F1 S20 20 32 180 5.4
Table 1.:  The influence of CBCT acquisition settings on the weighted computed tomography dose index (CTDI
w
). 
The first protocol corresponds to the preset Chest M20 protocol meaning medium field of view1. S20 
means small field of view. F1 means bowtie filter in place. 
1 Elekta Synergy XVI version 4.5. ‘Instructions for Use’ Manual, Elekta, UK, 2009
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The frequency of offset patient positioning amounted to 40.7% for the old full-rotation pro-
tocol, while this procedure was completely eliminated for the 205°-180°-rotation protocols.
DISCUSSION
In contrast to the previously studied protocols [12], the investigated protocols now involve a 
bowtie filter, a small FOV and a maximum range of projection views of 205°. Each of these 
factors is expected to affect body-contour accuracy, radiation dose to the patient and the 
need for offset patient positioning. For such special consideration performing a test is quite 
challenging as there are no existing image quality phantoms which could properly access 
reconstruction of superficial contours. Using anthropomorphic phantom (e.g. Alderson- 
Rando) for such purpose would not be feasible in prone position as the changes in breast 
shape could not be simulated representatively.
Firstly, our examination using the female cadaver clearly illustrated the suitability of a small 
FOV for breast CBCT, as all images included all main features for planning CT to CBCT 
registration: the breast contours, surgical clips and adjacent chest wall. Clinical implemen-
tation of the half-rotation rotation CBCT (for 558 acquisitions) did not reveal any relevant 
clinical differences compared to our test findings.
Moreover, our results clearly show that, even when using a bowtie filter that has been 
described to reduce panel saturation effects [13], attention regarding these artefacts and 
their effect on contour accuracy is required. Adoption of the preset tube current and expo-
sure time for CBCT imaging with bowtie filtration, only available for a medium FOV, resulted 
in an important periareolar tissue deficit in both prone and supine breast imaging with a 
small FOV. Our investigation showed that, even for CBCT protocols using a limited range 
of projection views, a reduction of tube current and exposure time completely eliminates 
these artefacts. A detailed description of such panel saturation effects and their relation 
to the CBCT tube current and exposure time is provided in [12]. The presence of these 
artefacts in the cadaver images clearly demonstrate the significance of panel saturation 
artefacts in a clinically relevant set-up.
As in the previous study [12], the phantom images still suffered from craniocaudal tissue 
excesses. These tissue excesses were ascribed to errors inherent to the FDK-based re-
construction algorithm and are most pronounced for flat object edges parallel to the imag-
ing module rotation plane [17]. In contrast, they were hardly found in the cadaver images, 
thus emphasizing the value of using phantoms that adequately reflect human anatomy 
for studying contour accuracy. Overall, the Thiel embalmed cadaver generally served as a 
clinically relevant phantom for CBCT acquisition: both clips, soft and hard tissue features 
were clearly visible and strongly resembled real patient geometry and composition. The 
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only limitation was the seeping of embalmment fluid into the cadaver lungs, resulting in a 
denser region near the chest wall on both the CBCT and planning CT images.
Additionally, the use of a small FOV has an important impact on patient radiation dose. 
In contrast to a medium FOV, the use of a small FOV allows for a reduction in range of 
projection views. While the transition from a medium to a small FOV for a given protocol 
resulted in a slight increase in CTDIw, lowering the range of projection views from 360° to 
205–180° allowed for a more important CTDIw reduction.
Note, however, that the concept of CTDIw was originally developed for reporting doses from 
CT acquisitions, representing the integral dose of a single CT slice [18]. These measure- 
ments are generally performed by integrating the dose measured in a 100 mm-long ion-
ization chamber, a technique that has also been adopted for CBCT by Amer et al. [19]. 
They showed that this approach results in a conservative overestimate of the weighted 
dose across the complete FOV, representing an estimate of the dose in the central 100 
mm of the FOV [19]. Moreover, the concept of CTDIw was designed for full-rotation acqui-
sitions with an axial-symmetric dose distribution [18]. CBCT acquisitions using a limited 
range of projection views obviously do not preserve this axial symmetry. The absorbed 
dose throughout the imaged volume will strongly depend on the location of the narrower 
entrance beams and the wider but attenuated exit beam, especially in the volume’s 
periphery [19]. In order to ensure a fair comparison between the different view ranges, the 
bisecting line of the range was always centered at 0°. Nevertheless, the application of the 
CTDIw concept in this paper was only used to provide a direct comparison between the 
investigated protocols, rather than quantifying absorbed doses for comparison with other 
imaging modules. To that purpose, a more elaborate investigation of the spatial distribution 
of radiation dose to the patient is required.
Furthermore, the use of a bowtie filter in the investigated protocols has been described to 
strongly reduce radiation dose to the patient [13]. This effect was found to be the most im-
portant in the peripheral regions of the scanned object, but was not investigated in this study.
An additional benefit of the use of a limited range of projection views is the avoidance 
of the offset procedure. As this intervention was completely eliminated with a range of 
protection views of 205°, it is also avoided in all protocols using a smaller range of projec-
tion views and the same physical central angle.
Stock et al. [8] observed a reasonable difference in image quality between CT and CBCT 
images. A limitation of this study is that the image quality is not objectively assessed. How-
ever the proposed protocol, currently used in our center, provides image quality that is 
sufficient for all radiation oncologists in our department to define translational positioning 
48
§ 4.  PU BL ICAT ION 2
errors. Current research can only be extrapolated to Elekta imaging modules and should 
not been generalized for other imaging entities.
CONCLUSIONS
The following CBCT acquisition parameters for supine and prone breast radiotherapy 
have been established: a 180° rotation, a small FOV, bowtie filtration, a tube current of 20 
mA and an exposure time of 32 ms. The use of this protocol results in adequate contour 
accuracy and eliminated the offset patient positioning procedure. Moreover, it allows for a 
decrease in radiation exposure, a 4.3-fold reduction in CTDIw was observed compared to 
the preset Chest M20 protocol.
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ABSTRACT
Background: Comparison of acute toxicity of whole-breast irradiation (WBI) in prone and 
supine positions.
Methods: This non-blinded, randomized, prospective, mono-centric trial was undertaken 
between December 29, 2010, and December 12, 2012. One hundred patients with large 
breasts were randomized between supine multi beam (MB) and prone tangential field 
(TF) intensity modulated radiotherapy (IMRT). Dose–volume parameters were assessed 
for the breast, heart, left anterior descending coronary artery (LAD), ipsilateral lung and 
contralateral breast. The primary endpoint was acute moist skin desquamation. Secondary 
endpoints were dermatitis, edema, pruritus and pain.
Results: Prone treatment resulted in: improved dose coverage (p<0.001); better homo-
geneity (p<0.001); less volumes of over-dosage (p=0.001); reduced acute skin desqua-
mation (p<0.001); a 3-fold decrease of moist desquamation (p=0.04 (chi-square), p=0.07 
(Fisher’s exact test)); lower incidence of dermatitis (p<0.001), edema (p=0.005), pruritus 
(p=0.06) and pain (p=0.06); 2- to 4-fold reduction of grades 2–3 toxicity; lower ipsilateral 
lung (p<0.001) and mean LAD (p=0.007) dose; lower, though statistically non-significant 
heart and maximum LAD.
Conclusions: This study provides level I evidence for replacing the supine standard treat-
ment by prone IMRT for whole-breast irradiation in patients with large breasts. A confirm-
atory trial in a multi-institutional setting is warranted.
INTRODUCTION
Adjuvant radiotherapy (RT) after breast conserving surgery halves the recurrence risk and 
reduces breast cancer death by about one sixth [1, 2]. Long-term epidemiological data 
showed that patients who received radiotherapy had an increased risk of death by cardiac 
events and increased risk to develop ipsilateral lung cancer and contralateral breast can-
cer [3-6]. Adverse effects that outweighed the benefits of radiotherapy on overall survival 
were observed in patients treated before the 1980’s [7]. Survival benefit in more recently 
treated patients correlates with lower radiation doses to the heart, lung and contralateral 
breast achieved by newer radiation techniques. Recent data of Darby et al. [6] showed a 
linear relationship between mean heart dose and rates of ischemic heart disease starting 
within a few years and continuing decades after breast RT. 
The supine patient position is part of the standard setup for breast RT and is associated 
with non-negligible acute toxicity even when intensity modulated radiation therapy (IMRT) 
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is used. Randomized controlled trials, comparing IMRT with non-IMRT, showed significant 
reduction of acute toxicity [8, 9], but still up to 40% of the IMRT-treated patients developed 
acute and late skin toxicity or breast fibrosis leading to discomfort and altered body image. 
Causes include volumes of over-dosage [dose levels higher than the prescribed range, 
i.e. between 95% and 107% of the prescription dose (PD)] in the breast and in folds that 
shield skin tissue from the protective build-up effects (in unfolded skin the maximum dose 
lays about 1.5 cm beneath the skin/air interface for 6 MV photon beams); both occur 
especially in larger breasts. Prone breast irradiation exploits gravity to elongate the treat-
ed breast away from the heart and lung. Formenti et al. [10, 11] demonstrated the clinical 
feasibility of this procedure resulting in further dose-reductions to heart and lungs, which 
have been confirmed by others [12-17]. As compared to supine, the prone position opens 
the infra-mammary fold, thereby restoring protective build-up, and reduces the radiological 
path-length i.e. the length of breast tissue traversed by tangential X-rays which helps 
reducing volumes of over-dosage.
 
With this rationale for prone breast RT we initiated a randomized controlled trial compar-
ing prone with supine position for large breasted patients. The primary objective was to 
test the hypothesis of decreased incidence of acute moist desquamation with prone IMRT, 
compared to our best supine technique: non-opposed multi-beam (MB) IMRT. Secondary 
endpoints included the analysis of acute and late skin toxicity, breast fibrosis, cosmetic 
alterations, quality of life and dose-volume parameters. Dose-volume parameter analysis 
included volumes of over-dosage in the treated breast and radiation doses delivered to 
volumes of organs-at-risk (OARs: heart, left anterior descending coronary artery (LAD), 
contra-lateral breast and ipsilateral lung). We, hereby, report on the primary objective of 
the study and on dose-volume parameters of treated breast and OARs.
MATERIALS AND METHODS
The study was designed as a non-blinded, randomized, prospective, mono-centric trial 
comparing prone and supine setup in patients who receive hypo-fractionated IMRT after 
breast-sparing surgery. Under the hypothesis of a 40% rate of moist acute skin desqua-
mation for supine-IMRT [8, 9] and 10% for prone-IMRT, at least 42 patients in each arm 
were needed for α = 0.05 and β = 0.1. The study was approved by the Ethics Committee of 
Ghent University Hospital (GUH) on June 10 2010 and registered under number 2009184 
(http://www.clinicaltrials.gov/ct2/show/NCT00887523).
Patients
Between December 29, 2010 and October 25, 2012, 100 female adult patients with Eu-
ropean cup size C or more were randomized to receive either supine or prone computed 
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tomography (CT)-simulation, planning and treatment. Cup size was based on patients’ 
bra size. If required, this was checked during clinical consultation by fitting bra models. All 
patients underwent breast-sparing surgery with a resection margin of ⩾1 mm, were lymph 
node negative and were appointed for WBI according to the multidisciplinary breast cancer 
board of GUH. Patients with previous breast radiotherapy or the need of bilateral breast 
irradiation were excluded from this trial.
Randomization and masking
All patients received oral and written information and signed written informed consent. 
After obtaining the informed written consent, patients were randomly assigned in a 1:1 ratio 
by the biostatistics unit of Ghent University Hospital. Each enrolled patient was allocated inde-
pendently from the study investigators and the treatment arm was revealed at the day of the 
simulation. The analysis is based on clinical data that were collected till December 12 2012.
Treatment techniques
The prone tangential field (TF), 2 beam-IMRT technique was described by Veldeman et 
al. [14, 15]. A 6 beam-IMRT technique with 3 medial and 3 lateral beams, non-opposing, 
was applied in supine position [18]. Figure 1 shows prone positioning using the unilateral 
breast holder (U-BH) developed by Van de Velde (Schellebelle, Belgium) and the prone 
breast board constructed by Orfit Industries (Wijnegem, Belgium) used in this trial.
OARs and target volumes were delineated as previously described [14]. The groove 
between the left and right ventricles was used as landmark whenever visualization of the 
LAD was difficult. A planning target volume (PTV) was generated to account for anatomical 
changes and setup variability during treatment. A planning target volume for optimization 
(PTV
optim) was created by extracting the in-air part of the PTV and an additional 7 mm skin-
zone of the PTV to exclude most of the build-up regions of photon beams.
A prescription dose (PD) of 40.05 Gy in 15 fractions was delivered to the whole breast [10, 19]. 
A boost of 10 Gy in 4 fractions was given to the tumor bed in 75 patients (39 supine and 36 
prone). The PTV
optim dose distribution was evaluated by the dose coverage index (proportion 
of the volume covered by the 95–107% range of the PD); the maximum and minimum dose 
(D
max
 and D
min), i.e. the dose levels that are exceeded in, respectively 2% and 98% of the vol-
ume; the dose homogeneity index (1−((D
max
 − D
min)/D50) where D50 is the median dose) and 
the volumes receiving ⩾105% and ⩾107% of the PD (V105 and V107 (volumes of over-dosage), 
respectively). Plan evaluation for the OARs was performed using mean dose (D
mean
), D
max
 and 
the partial volumes receiving more than 5 Gy and 20 Gy (V5 and V20), respectively. Dose-vol-
ume data for heart and LAD were analyzed for the patients receiving treatment to the left breast. 
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Figure 1.:  Patient set-up devices for prone CT-simulation and treatment: (A) Unilateral breast holder to retract the 
contra-lateral breast away from the treated breast. (B) Prone breast board: 1: hand grip; 2: head rest; 
3: carbon fiber wedge support of the contra-lateral breast; 4: numeric scale (at both sides of the cau-
dal part) to adjust table height using the in-room laser system; 5: safety belt. (C) Ipsilateral (left panel) 
and contralateral (right panel) views of a patient positioned on the breast board.
 
Toxicity
Acute toxicity was evaluated before treatment, weekly during irradiation and 1–2 weeks 
after completion of RT by a radiation nurse and a radiation oncologist. The following pa-
rameters were scored: dermatitis, pruritus and pain using the common terminology criteria 
for adverse events v3.0 (CTCAEv3) [20]: desquamation was evaluated as 0 = none, 1 = 
dry and 2 = moist; edema as 0 = none, 1 = asymptomatic and 2 = symptomatic. General 
recommendations during the first clinical consultation (no bathing, rubbing or application 
of cosmetic products other than the ones prescribed according to departmental guidelines) 
were made to avoid bias of results due to differences in skin care. Pruritus, dry desquama-
tion and faint to brisk erythema were treated with local application of a cold cream with 5% 
urea. If insufficient a corticoid cream was added for a maximum period of 3 weeks. Moist 
desquamation was handled with Mepilex®, a self-adhesive silicon-containing material.
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Statistics
Statistical analysis was performed using SPSS 20.0 software (SPSS Inc., Chicago, IL). 
A p-value of <0.05 was considered statistically significant. Frequencies of toxicity param-
eters between the prone and supine cohort were analyzed using a chi-square test if as-
sumptions were satisfied (expected cell counts >5); otherwise Fisher’s exact test was per-
formed, except for the primary endpoint where both tests were performed; an independent 
two sample t-test was used to compare dosimetric means and chi-square/Fisher’s exact 
test to relate dose–volume parameters with toxicity frequencies.
RESULTS
100 patients were randomized: 50 patients were allocated to prone treatment, 50 to 
supine treatment. Characteristics of both patient cohorts are presented in table 1. Patient 
groups were well balanced: there were no statistically significant differences in age, body 
mass index (BMI), cup size, breast volume, T-stage, systemic therapy or boost irradiation.
Characteristics Treatment group p-value
Supine Prone
Age (y) 59.6 (35-80) 58.1 (39-78) 0.49
BMI 27.3 (19.5-44.3) 27.1 (19.1-38.4) 0.76
Cup size
C 31 27
0.70
D 14 15
E 4 5
≥F 1 3
Breast volume (cc) 975 (412-2097) 1011 (434-2294) 0.93
T-stage
Is 2 2
0.73
1a 0 3
1b 12 11
1c 23 23
2 13 11
Side Left 29 31 0.68
Right 21 19
Chemotherapy No 38 35 0.50
Yes 12 15
Hormone therapy No 7 9 0.59
Yes 43 41
Trastuzumab
No 48 45
0.44
Yes 2 5
Boost
No 11 14
0.49
Yes 39 36
Table 1.: Patient characteristics.
Numerical values indicate number of patients, unless otherwise indicated. Mean (range) was used to express 
BMI, age and breast volume. 
Abbreviations: BMI = body mass index, T-stage = tumor stage, boost = sequential boost. 
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Acute Toxicity
Prone positioning reduced desquamation, dermatitis, edema, and pain significantly com-
pared to the supine patient cohort (Figure 2). Three prone treated patients versus 10 su-
pine treated patients had moist desquamation (p=0.04 (chi-square), p=0.07 (Fisher’s exact 
test)). Dermatitis grade 2–3 was halved (19/50 prone patients vs. 40/50 supine patients; 
p<0.001 (chi-square)) in prone position. Confluent moist desquamation outside the skin 
folds, i.e. grade 3 dermatitis, was absent in the prone cohort while it occurred in 2 patients 
of the supine cohort. Prone position resulted in a 3-fold decrease (6/50 prone patients 
versus 18/50 supine patients; p=0.005 (chi-square)) of grade 2 edema. Differences were 
not statistically significant for pruritus. Pain occurred less frequently in prone compared 
to supine patients (28 versus 37 patients; p=0.06 (chi-square)); in particular severe pain 
(2 versus 8 patients: p=0.09 (Fisher’s exact test)).
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Figure 2.:  Maximum grade of acute toxicity. The vertical axis indicates number of patients. The horizontal axis 
shows grade of desquamation (scored as none (0), dry (1) or moist (2)), dermatitis, pain, pruritus 
(scored using the common terminology criteria for adverse events v3.0) and edema (scored as none (0), 
asymptomatic (1) or symptomatic (2)) for the supine-(grey) and prone-treated (black) patient cohorts.
Plan evaluation
Table 2 shows the dosimetric evaluation of the PTV
optim and OARs. The dose distribution in 
the treated breast was significantly different between treatment arms: higher dose cover-
age index (p<0.001), dose homogeneity (p<0.001) and smaller volumes of over-dosage 
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(p=0.001) were observed in prone position. Moreover, doses exceeding V105 and V107 
occurred in 48/50 and 38/50 patients of the supine cohort versus 34/50 and 17/50 pa-
tients of the prone cohort, respectively. The International Commission on Radiation Units 
& Measurements (ICRU Reports 50 and 62) recommends considering over-dosage vol-
umes with a diameter ⩾15 mm (≈1.75 cc) as clinically significant. Over-dosage volumes 
⩾1.75 cc occurred in 7/50 and 25/50 patients in the prone and supine cohorts, respec-
tively (p<0.001). Heart dose parameters (D
mean
, D
max
, V5, V20) showed lower averages for 
the prone-treated cohort, though non-significant. The LAD dose parameters (D
mean
, D
max
) 
showed lower averages in the prone-treated cohort position reaching significance for D
mean
. 
Lung dose parameters were drastically reduced (p<0.001) in prone position. The contralat-
eral breast was spared in both procedures: none of the patients received a D
max
 of ⩾5 Gy 
or a D
mean
 ⩾1.0 Gy.
Organ Dose/volume Treatment group p-value
Supine Prone
PTV
optim Coverage (%) 92.7±4.9 96.2±2.2 <0.001
Homogeneity 0.87±0.04 0.90±0.04 <0.001
V105 (cc) 30.9±40.4 8.9±17.7 <0.001
V107 (cc) 7.6±12.6 0.9±2.7 <0.001
Heart D
mean 
(Gy) 2.0±1.1 1.5±0.6 0.08
D
max 
(Gy) 12.1±9.5 9.7±6.5 0.25
V5 (%) 5.9±5.5 3.8±3.9 0.09
V20 (%) 1.4±2.3 0.7±0.9 0.12
LAD D
mean 
(Gy) 9.3±6.5 5.4±3.7 0.007
D
max 
(Gy) 23.0±11.7 19.5±11.1 0.25
Ipsilateral Lung D
mean 
(Gy) 3.8±1.1 1.1±0.9 <0.001
D
max 
(Gy) 26.6±6.5 8.6±8.9 <0.001
V5 (%) 16.9±5.7 2.9±3.7 <0.001
V20 (%) 5.5±3.3 0.9±2.1 <0.001
Table 2.: Dose/volume statistics.
Mean ± standard deviation for dose coverage index (Coverage), dose homogeneity (Homogeneity) and volume 
receiving ⩾105% (V105) and ⩾107% (V107) of the prescription dose in the planning target volume for optimiza-
tion (PTVoptim); heart, left anterior descending coronary artery (LAD), ipsilateral lung mean dose (Dmean), max-
imum dose (Dmax) and partial volume receiving ⩾5 Gy (V5) and ⩾20 Gy (V20). Dose–volume data for heart and 
LAD were analyzed for patients treated to the left breast. Statistically significant results (p<0.05) are highlighted.
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Relationship between dose-volume parameters and toxicity
Dose homogeneity <85% was related (p=0.005) to dermatitis; dose homogeneity <90% 
to edema (p=0.001) and to pain (p=0.05). Presence of high-dose volumes ⩾105% and 
⩾107% of the PD was related to increased desquamation (both, p=0.002), dermatitis 
(p=0.003 and <0.001), edema (p=0.008 and <0.001) and pain (p=0.03 and 0.01).
DISCUSSION
Improved target dose homogeneity and the avoidance of volumes of over-dosage have 
been suggested as factors for decreased breast toxicity [8, 21]. The present study confirms 
existing knowledge [16, 22, 23], that prone position allows for further improvements in target 
dose homogeneity and avoidance of volumes of over-dosage beyond what is achievable 
with supine IMRT. The results support the hypothesis that dosimetrical improvements in 
the treated breast results in less acute toxicity. 
Our study enrolled patients with voluminous breasts because literature data showed 
increasing whole breast irradiation (WBI)-induced skin toxicity with breast size [8, 24]. 
Pignol et al. [8] observed a moist desquamation rate of 31.2% using supine IMRT in 
a patient group with large and small breast size. Our large-breasted supine cohort 
developed moist desquamation in only 20% of the population, which might be explained 
by the use of a MB-IMRT technique. Hence, the moist desquamation rate in our con-
trol group seems relevant for what can be achieved in supine position. Still a 3-fold 
reduction of moist desquamation was observed in the prone group. Dermatitis grade ⩾2 
was observed 2-fold less frequently in the prone (38%) than in the supine group (80%). 
Grade 3 dermatitis occurred only in 4% of the supine treated patients and in none of the 
prone treated patients. Bergom et al. [22] reported a dermatitis grade 2 and 3 respec-
tively in 67.3% and 4.5% of prone treated patients. The differences with our trial might 
be related to the use of IMRT, which, also in the prone position, has been shown to 
improve the dose distribution in the treated breast and to reduce skin toxicity [25]. Our 
entire supine cohort developed edema, while edema was absent in 5 prone-treated 
patients. Pain was reported less frequently and was less severe in the prone-treated group. 
This is not surprising since desquamation, dermatitis and edema are significantly corre-
lated with pain. A limitation of this study is the non-blinded setting of toxicity evaluation 
and topical treatment, however our aspiration was to score objectively using the validated 
standardized scoring scales for side effects (CTCAEv3; desquamation as 0 = none, 1 = 
dry and 2 = moist and edema as 0 = none, 1 = asymptomatic and 2 = symptomatic). Our 
randomized controlled trial confirms low acute toxicity in a prone patient cohort, as men-
tioned by others [10, 22, 25, 26].
59
§ 5.  PU BL ICAT ION 3
In cohorts of patients treated after 1983 no increase of radiation-related cardiac mortality 
was reported [3]. However, it is well documented that modern radiation techniques still 
cause cardiac injury [27-29] and that odds ratios of radiation-related cardiac mortality may 
still increase after 20 years of follow-up [3, 6]. Moreover, recent data [6] suggest that the 
relative risk of major coronary events increase linearly with mean heart dose by 7.4% per 
Gy, with no apparent threshold dose. The MB-IMRT technique used in the supine-treated 
patients of this study was designed to reduce lung and heart irradiation [18]. Mean heart 
doses in the supine-treated patients were low as compared to literature data [30]. Formenti 
et al. [10, 11] observed that heart dose reduction by prone positioning remained possible 
for the majority of patients, which was confirmed by others [12-14, 16, 17, 24, 31]. More-
over Formenti et al. [11], Lymberis et al. [13] and Kirby et al. [12] correlated the benefit of 
prone position to breast-volume; reduced heart doses are observed in all large-breasted 
patients treated in prone position, while in some patients with small breast size the advan-
tage of prone positioning on heart dose might be absent. Extrapolation of Darby’s findings 
[6] to our data results in a decrease of 3.7% of major coronary events-risk in our prone 
cohort compared to the supine cohort. This effect might be less pronounced when other 
supine techniques to improve heart dose metrics like moderate deep inspiration breath 
hold (mDIBH) or respiratory gating are used [32, 33]. However, we obtained similar 
dose-volume parameters for heart in another study comparing shallow breathing in prone 
with voluntary mDIBH in supine position (paper submitted).
In the most recent analysis of Darby, the increase in number of lung cancer deaths (ipsilat-
eral versus contralateral) exceeded the increase in number of cardiac deaths (left versus 
right) for the cohorts treated from 1983 on [3]. Reports on the ipsilateral lung mean dose 
show average values between 7 and 18 Gy [3]. With a group-average of 3.8 ± 1.3 Gy in the 
supine treated patients, ipsilateral mean lung dose was comparable to the values reported 
in study by Kirby (4.4 (3.5–5.2) Gy) [12]. For prone-treated patients ipsilateral lung mean 
dose was more than 3-fold reduced to a group-average of 1.1 ± 0.9 Gy in this study and 
0.8 (0.3–1.4 Gy) in the study of Kirby [12]. A strong dose reduction in lung dose by switch-
ing to prone is a robust observation since it cannot only be demonstrated on a population 
basis but also for each individual patient in whom comparative plans are made [11-17, 31].
In the present era of high-tech radiation therapy, it is a remarkable finding that a simple prone 
technique employing 2 tangential IMRT fields yields better target dose-distributions and 
OARs-sparing and is associated with less acute toxicity than a more sophisticated MB-IM-
RT technique in supine position. Taking all evidence together, a technique change from the 
supine standard to prone IMRT could be considered in all patients with right-sided tumors, 
in patients with left-sided tumors and large breasts and in patients with left-sided tumors 
and small breasts in whom comparative planning shows an advantage for prone position.
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ABSTRACT
Background and purpose: Feasibility of deep inspiration breath hold (DIBH) in the prone 
position to reduce heart dose for left-sided whole breast irradiation (WBI).
Material and methods: Twelve patients underwent CT-simulation in supine shallow 
breathing (SB), supine DIBH, prone SB and prone DIBH. A validation cohort of 38 patients 
received prone SB and prone DIBH CT-scans; the last 30 patients were accepted for prone 
DIBH treatment. WBI was planned with a prescription dose of 40.05Gy.
Results: DIBH was able to reduce (p<0.001 by the Friedman test) heart dose in both 
positions. Results for prone DIBH were at least as favorable as for supine DIBH, while 
preserving the lung sparing ability of prone positioning. Pooling the data for prone, a max-
imum heart dose <10Gy was observed in 18/50, 47/50, 1/12 and 7/12 patients for prone 
SB, prone DIBH, supine SB and supine DIBH, respectively. Mean heart dose was low-
ered from 2.2Gy for prone SB to 1.3Gy for prone DIBH (p<0.001 by the Wilcoxon test). 
All patients were able to perform the simulation procedure, 28/30 patients were treated 
with prone DIBH.
Conclusions: This trial demonstrates the ability and feasibility of prone DIBH to acquire 
optimal heart and lung sparing for left-sided WBI.
INTRODUCTION
A significant overall survival benefit is observed when whole breast irradiation (WBI) is 
added to breast conserving surgery in the primary treatment of early-stage breast cancer 
[1]. However, it has also been recognized that breast radiotherapy is associated with an 
increase in non-breast cancer related deaths [2-8]. Excess radiation-induced mortality is 
primarily attributed to cardiovascular disease and in early trials the gain in breast cancer 
specific survival was even offset by the increase in cardiac deaths [3]. Heart and left ante-
rior descending coronary artery (LAD) dose have been related to cardiovascular disease 
in patients irradiated for left-sided breast cancer [2-6]. Darby et al. [2] demonstrated that 
relative risk of major coronary artery events increase linearly by 7.4% per Gy mean heart 
dose, with no apparent threshold dose. Long-term epidemiological data also showed that 
patients who received radiotherapy for breast cancer had an increased risk to develop 
contralateral breast cancer, ipsilateral lung cancer, pneumonitis and lung fibrosis [4-8]. 
The anatomical advantages associated with a shift from supine to prone position – i.e. the 
breast elongates and falls away from the intra-thoracic organs at risk (OARs) – have been 
published in pioneering work by the New York University group and Royal Marsden group 
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of London. Studies comparing supine and prone WBI have demonstrated the ability of 
prone position to reduce lung volume exposed to radiation [9-15]. A drawback of prone WBI 
is the gravity-induced anterior displacement of the heart towards the irradiated region [16]. 
Still, Formenti et al. [10] demonstrated that prone WBI seems to be beneficial for 85% of 
the patients regarding heart irradiation. However, increased heart doses are of concern in 
a substantial fraction of patients, especially those with small breast volume [9-12]. Irradia-
tion during deep inspiration has been successfully implemented in supine WBI to reduce 
heart dose without increasing dose to other OARs [17-25]. Deep inspiration breath hold 
(DIBH) increases the distance between heart and breast. If this effect occurs in prone po-
sition, DIBH might further reduce heart dose in the majority of patients and may address 
the problem of higher heart dose in prone than supine for the specific subgroup of patients.
This study is the first to report on DIBH in prone position for left-sided WBI. The primary 
endpoint was the effect of prone DIBH on heart dose metrics; secondary objectives were 
non-heart tissue dosimetry, clinical feasibility and acute toxicity.
MATERIALS AND METHODS
Two (consecutive) trials were performed. A first CT-simulation and planning study was con-
ducted at Clinique et Maternité Sainte-Elisabeth (CMSE), Namur to investigate if DIBH 
could lower heart dose as efficiently in prone position as in supine while keeping its su-
periority regarding lung dose. CMSE has solid experience in supine DIBH [25]. Using the 
experience acquired at CMSE the second trial was conducted at Ghent University Hospital 
(GUH) where the prone position is used as a standard treatment option for WBI [12]. First, 
it aimed at reproducing the CT-simulation and planning results of prone DIBH obtained 
at CMSE. The second objective was to investigate the feasibility of prone DIBH treatment. 
Patients
The first (CMSE) and second (GUH) trial enrolled 12 and 38 patients, respectively. All 50 
patients underwent breast-sparing surgery for left-sided breast cancer and were eligible for 
WBI according to the multidisciplinary breast cancer board at CMSE or GUH. The CMSE 
study group received 4 computed tomography (CT) scans for radiotherapy planning: in 
supine and prone position, both with and without the DIBH maneuver. The GUH study 
group received only two planning CT scans: prone SB and prone DIBH. The CMSE study 
group was treated in supine position with the breath hold maneuver if indicated. The first 
eight patients of the GUH study were part of a learning-phase of the CT-simulation and 
planning procedure and were treated in prone SB; the last 30 patients were accepted for 
prone DIBH treatment. 
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During clinical consultation, the maneuver of the voluntary DIBH was explained, demon-
strated and rehearsed as described elsewhere [25]. In brief, patients were educated to 
execute two “preparatory“ deep inspirations before holding their breaths at a level of deep 
inspiration which they could maintain for 15-20 seconds. This training took five to ten min-
utes. At GUH, a figure of the prone setup and an audio-file containing the sequence of the 
breath hold technique were mailed to the patients for practicing at home. The same audio 
sequence was used during simulation and treatment. The DIBH maneuver was briefly 
rehearsed before the start of the simulation procedure.
Simulation procedure
At CMSE, supine positioning was executed on a Breast Step System® (Elekta, Crawley, 
UK); prone positioning was previously described by Veldeman et al. [14, 15] and performed 
on a prone-lateral Horizon breast board (Civco Medical Solutions, Orange City, Iowa, USA). 
The breathing cycles were additionally monitored using a Varian Real-time Position Manage-
ment system (RPMTM) positioned at the dorsal side of the thorax. After positioning, the DIBH 
was rehearsed with audio-coaching using a telecom system. Thorax expansion was visually 
checked and breathing cycles were documented with the RPMTM. When needed, verbal 
feedback was given to the patient. First supine SB and supine DIBH CT-acquisition were 
performed, afterwards prone SB and prone DIBH; the CT-acquisition time did not exceed 
15-20 seconds. Neither scan range nor patient position were altered between SB and DIBH.
Figure 1A shows the workflow during simulation at GUH. A modified prone-lateral breast 
board fabricated by Orfit Industries (Wijnegem, Belgium) was used for prone positioning 
[26]; the breathing curves were registered using an emitting and receiving magnetic probe 
(Respisens magnetic sensors, Nomics, Angleur, Belgium) positioned at the lateral dorsum 
of the thorax and breast board [15, 25].  
Figure 1A.: Chain of procedures executed during simulation. 1) Prone positioning and placement of the Respisens 
probes (arrows). The upper probe is taped to the lower lateral thoracic wall. The lower probe is taped 
to the breastboard. The Respisens system continuously measures the distance between upper and 
lower probes. 2) Rehearsal of the deep inspiration breath hold (DIBH)-procedure and feedback to the 
patient. 3) Prone shallow breathing (SB) scan with isocenter definition and drawing of skin marks for 
positioning. 4) Prone DIBH scan (DIBH) for treatment planning. 
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Planning
Delineation of the target volumes and OARs (heart, LAD, heterolateral breast and lungs) 
was done as reported in previous publications [12, 14, 15, 26]. A two-beam (CMSE) and 
two-arc (GUH) intensity modulated technique were used. A median dose of 40.05Gy was 
prescribed to the whole breast in 15 fractions of 2.67Gy. Plan evaluation for heart, LAD, 
hetero-lateral breast and ipsilateral lung was performed using mean dose (D
mean
) and the 
dose that is exceeded in 2% of the volume as surrogate for maximum dose (D
max
) [12, 26]. 
For patients to be treated with prone DIBH the beam-on time for each treatment field was 
computed when the treatment plan was finished. The beam was divided into parts of less 
than 18 seconds if the beam-on time exceeded the predefined breath hold limit of 18 sec-
onds. This duration was empirically chosen in order to avoid shortness of breath during 
treatment.
Treatment and acute toxicity
Prone DIBH treatment was performed on an Elekta Synergy linear accelerator (Elekta, 
Crawley, West-Sussex, United Kingdom). If required, a sequential boost was given in four 
to six fractions according to the department’s guidelines. Figure 1B shows the workflow 
executed during treatment. Prone positioning was done in SB and vertical, lateral and longi- 
tudinal setup errors were corrected on a daily basis using cone beam CT with adapted 
parameters [27]. The CBCT-scan wasn’t taken in prone DIBH since CT-acquisition takes 
at least 20-25 seconds and might be too long for patients to hold their breath. Afterwards, 
a lateral kV-image was acquired during DIBH and vertical and longitudinal errors were 
corrected based on the fusion with a DRR generated from the DIBH-scan. The systematic 
and random setup error for each individual patient was defined as the mean and standard 
deviation of all shifts in the vertical and longitudinal directions. The population systematic 
setup error (M) was calculated as the average of all means; the population standard deviation 
Figure 1B.: Chain of procedures executed during treatment. 1) Prone positioning and placement of the Respis-
ens probes. 2) Rehearsal of the DIBH-procedure and feedback to patient. 3) Correction of the trans-
lational errors of prone SB using cone beam CT (CBCT). 4) Adjustment of prone DIBH setup errors 
using lateral kV-kV imaging. 5) Prone DIBH-treatment (Tn).  
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of the systematic setup error (Σ) was computed as the standard deviation of all means; 
the population random setup error (σ) as the root mean square of all individual standard 
deviations [28]. 
Elekta synergy linear accelerators impose a delay of 4 to 5 seconds between pressing the 
beam on-button on the console and the actual start of irradiation. Therefore we generated 
a movie with the input of the moment of pushing the button in the DIBH audio-sequence. 
In brief, while the patient heard the DIBH-sequence in the treatment room, there was a 
down timer which the nurses could see on the computer screen and approximately 2 
seconds before the patient had to hold their deep breath the nurses had to push the beam 
on-button. If the patient wasn’t able to reach the DIBH in time an interrupt button could be 
used, which wasn’t necessary in our cohort. 
Acute toxicity was evaluated before, weekly during and 1-2 weeks after completion of RT. 
Desquamation was scored as 0=none, 1=dry and 2=moist; edema as 0=none, 1=asymp-
tomatic and 2= symptomatic; dermatitis and pain were reported using the using the com-
mon terminology criteria for adverse events v3.0 [26]. 
Statistics
Statistical evaluation was performed using SPSS 20.1 software (SPSS Inc., Chicago, IL). 
A p value ≤0.05 was considered statistically significant. The non-normal distribution of 
dosimetric parameters was documented by the Shapiro-Wilk test (p<0.05) and by Q-Q 
plots. The 2-sided Wilcoxon signed rank test (GUH study group) and Friedman’s test 
(CMSE study group) were conducted to evaluate dose metrics for heart, LAD, ipsilateral 
lung and both breasts. 
RESULTS
Patient characteristics for the whole population are: median age = 55 years (range, 39-72); 
median body mass index = 27 (range, 17-39) and median breast volume (prone SB) = 
899cc (range, 176-3693). Figure 2 shows the location of the heart observed with prone 
DIBH compared to prone SB. As in supine position, the heart is shifted caudally, medially 
and posteriorly (arrow number 3), with almost no displacement of the treated breast. 
The effect of the DIBH maneuver in prone and supine position is illustrated in Figure 3, 
which shows the typical dose distributions in a transverse plane of a patient in supine SB, 
supine DIBH, prone SB and prone DIBH.
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Figure 2.:  Rigid coregistration, based on couch and breast board, of CT-scans in a transverse and a sagittal plane 
during shallow breathing (dark grey) and deep inspiration breath hold (light grey) in prone position. (1) 
thoracic expansion, (2) caudal shift of the diaphragm and (3) narrowing and caudal motion of the heart.
Figure 3.:  Typical isodose distribution of a patient in supine shallow breathing (SB), supine deep inspiration breath 
hold (DIBH), prone SB and prone DIBH in the transverse plane through a radio-opaque clip (indicated 
with red arrow). 
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Table 1 provides population averages for heart, LAD and ipsilateral lung dose metrics. In 
the CMSE study, we observed that prone DIBH was at least as favorable as supine DIBH 
for heart and LAD sparing. The heart dose/volume results of the CMSE study were repro-
duced in the GUH study. Figure 4 provides an overview of the individual prone heart D
mean
 
and D
max
 of the whole patient group cohort ranked according to decreasing dose-difference 
between prone SB and prone DIBH. Prone DIBH was able to lower the heart D
max
 to less 
than 10Gy in 47/50 patients while for prone SB this was only achieved in 18/50 patients 
(the figures for supine (CSME study group) are 7/12 and 1/12 patients, respectively). 2/12 
patients had a lower heart D
max
 in supine DIBH, however in dose ranges <10Gy. In only 
two patients prone DIBH failed to obtain a heart D
mean
 of <2Gy. The first patient present-
ed with an extremely medial, nearly presternal located tumor bed, while the other patient 
had the largest breast volume of our study population (3693cc). As mentioned above, with 
prone DIBH a D
max
 of ≥10Gy was observed in 3/50 patients. Two of these patients had a 
total lung volume expansion of 22.6% and 23.0% while the average for the whole popula-
tion was 58% (± 27%), suggesting that they had difficulties to perform a deep inspiration 
in the prone position. Both women were obese with a BMI of 35 and 31, respectively and 
the former patient was actively smoking and had a 30 pack year history. The third patient 
was the one with the presternal located tumor volume. Reductions in heart D
max
 with prone 
DIBH compared to prone SB according to breast volume <750cc (18 patients), 750-1500cc 
(22 patients) and >1500cc (10 patients) were 15.9Gy (± 10.4Gy), 9.0Gy (± 8.2Gy) and 
5.0Gy (± 5.7Gy), respectively. Heart D
mean
 reductions were 1.3 (± 0.9Gy), 0.7 (± 0.7Gy) and 
0.4 (± 0.4Gy) in the three groups, respectively. Prone radically achieved better ipsilateral 
lung dose metrics compared to supine position (CMSE cohort). Slightly better (p<0.01) 
lung dose metrics were observed in prone SB compared to DIBH (GUH cohort); however 
results were in similar low dose regions. The planning goal of a D
max
 <5Gy and a D
mean
 
<1Gy to the contralateral breast was obtained for all techniques. 
Figure 4.: Plots of individual heart mean (D
mean
) and maximum (D
max
) dose for prone shallow breathing (SB) and 
prone deep inspiration breath hold (DIBH) ranked according to decreased effect of the DIBH maneuver. 
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All patients were able to perform prone positioning while holding their breaths for repeti-
tive periods of at least 15 seconds during simulation. Two of the 30 patients addressed for 
prone DIBH treatment were re-simulated and treated in supine position; one patient due 
to severe abdominal pain caused by prone positioning during the first treatment fraction, 
the other was the above mentioned patient with the presternal located tumorbed. All other 
patients were able to perform repetitive prone DIBH cycles during treatment, no treatment 
interruptions had to be made. 
Table 2 shows individual and population systematic and random setup errors in the vertical 
and longitudinal axis for prone DIBH after correction of translational errors during SB. 
A positive value indicates an anterior or cranial shift for the vertical or longitudinal axis, 
respectively. The population systematic error was close to zero (0.1mm and -0.4mm in the 
vertical and longitudinal directions, respectively). The population random error was 2.0mm 
for the vertical and 1.7mm for the longitudinal direction. None of the prone DIBH treated 
patients developed acute grade III toxicity. Moist desquamation occurred in 2/28 patients, 
while 11/28 patients developed dry desquamation. Grade I and II acute toxicity occurred in 
14/28 and 13/28 patients for dermatitis, 13/28 and 4/28 patients for edema and 6/28 and 
4/28 patients for pain, respectively. 
Supine SB
Supine
 DIBH
Prone SB Prone DIBH
Friedman’s
 test
Wilcoxon
 test
CMSE CMSE CMSE GUH All CMSE GUH All p-value p-value
Heart D
mean 
(Gy) 4.0±1.8 2.2±1.2 2.5±1.1 2.1±0.7 2.2±0.8 1.4±0.4 1.3±0.3 1.3±0.3 <0.001 <0.001
D
max 
(Gy) 29.3±10.6 14.6±12.0 19.6±13.1 15.1±8.6 16.2±9.9 5.3±2.0 5.6±3.6 5.5±3.3 <0.001 <0.001
LAD D
mean 
(Gy) 17.6±7.2 10.9±7.8 12.0±7.1 7.1±3.9 8.3±5.3 4.1±1.6 3.1±1.9 3.3±1.8 <0.001 <0.001
D
max
 (Gy) 36.1±7.5 25.5±12.4 29.8±8.0 25.6±10.5 26.6±10.0 14.9±6.6 12.2±9.1 12.9±8.7 <0.001 <0.001
Lung volume (cc) 1235±485 2090±557 1258±310 1159±226 1182±249 1839±509 1848±426 1845±442 <0.001 <0.001
D
mean 
(Gy) 5.5±1.8 5.0±1.8 0.8±0.3 0.9±0.7 0.9±0.6 0.7±0.2 1.0±0.7 0.9±0.4 <0.001 0.003
D
max 
(Gy) 35.6±4.1 33.5±10.3 6.1±7.1 6.2±7.4 6.2±7.3 4.7±3.8 7.7±6.5 7.0±6.1 <0.001 0.005
Table 1.: Dose metrics.
Mean ± standard deviation for heart, left anterior descending coronary artery (LAD) and ipsilateral lung (lung) 
dose metrics for the CMSE study group involving 12 patients who underwent shallow breathing (SB) and deep 
inspiration breath hold (DIBH) in the supine and prone position and for the GUH study group involving 38 patients 
who underwent prone SB and prone DIBH. The Friedman’s test and Wilcoxon test was used to analyze dose-vol-
ume parameters for the CMSE and GUH cohort, respectively. Abbreviations: CMSE = Clinique et Maternité 
Sainte-Elisabeth, Belgium; GUH = Ghent University Hospital, Belgium; D
max
 = maximum dose; D
mean
 = mean dose. 
72
§ 6 .  PU BL ICAT ION 4
Patient Vertical(mm) Longitudinal(mm)
m SD m SD
1 -0.3 1.0 -0.5 1.0
2 -0.1 0.9 0.2 0.6
3 4.4 2.3 0.5 1.5
4 1.7 1.8 0.0 1.9
5 -1.5 1.5 -0.3 0.7
6 -1.3 2.2 -0.1 0.5
7 0.0 0.0 0.0 0.0
8 -0.2 2.2 0.2 0.8
9 -1.4 2.4 -1.2 2.3
10 -4.5 2.4 0.3 1.2
11 0.1 1.2 -0.8 1.2
12 0.8 1.3 -0.2 1.7
13 4.0 1.6 -1.3 2.0
14 0.3 1.1 -0.1 0.5
15 -1.1 1.8 -0.6 1.8
16 0.2 0.9 -0.2 0.6
17 -0.9 2.8 -0.9 2.4
18 -0.4 3.0 0.1 2.1
19 1.2 1.6 0.2 0.7
20 1.1 1.2 -0.5 1.4
21 -0.1 0.5 -0.3 1.0
22 2.4 3.5 -0.9 2.2
23 -0.2 0.6 -0.5 2.1
24 0.0 1.1 -0.1 1.3
25 -0.1 0.4 0.0 0.0
26 1.1 2.0 0.2 2.1
27 -2.4 4.9 -4.7 4.1
28 0.3 1.4 -0.8 3.1
M 0.1 -0.4
Σ 1.7 0.9
σ 2.0 1.7
Table 2.: Individual and population systematic and random setup errors of prone deep inspiration breath hold af-
ter translational error correction of prone shallow breathing. A positive value indicates an anterior or 
cranial shift in the vertical or longitudinal axis, respectively. Abbreviations: m = individual systematic 
setup error; SD = individual random setup error; M = population systematic setup error; Σ = standard 
deviation of M; σ = population random setup error.
DISCUSSION
Breast cancer patients are long-term survivors and using techniques that potentially 
reduce radiotherapy-related toxicity is crucial. Heart disease after breast irradiation is well 
documented and of major concern [2-6]. Darby et al. [2] demonstrated a linear relationship 
between mean heart dose and relative risk of ischemic heart disease starting within a few 
years and continuing decades after breast RT, with no apparent threshold dose. In agree-
ment with others [17-24], our results demonstrated a reduction of heart dose with DIBH 
in the supine position. Lymberis et al. [11] reported that the majority of left-sided breast 
cancer patients benefits from prone compared to supine position regarding heart dose. 
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Our shallow breathing data indeed demonstrated better population averages for heart 
sparing in prone compared to supine position. 
In prone position, deep inspiration might be difficult because thoracic expansion is hin-
dered in the anterior direction by the breast board. The average ipsilateral lung volume 
increase was about 30% smaller in prone than in supine position. In 2 of the patients (both 
obese) with a heart D
max
 >10Gy the lung volume expansion with breath hold was less than 
half of the population average, suggesting that these patients had difficulties to perform 
a deep inspiration in prone position. Still, the population average effect of DIBH on heart 
D
mean
 was 0.9Gy in prone position, which would translate to a risk reduction of major car-
diac ischemic events of 6.7% (range, 21.9% - 0.1%) [2]. Moreover population averages 
for heart and LAD dose metrics of prone DIBH were at least as favorable as supine DIBH 
(table 1). Though, in some patients, the advantages of DIBH in the prone position might 
be limited (figure 4). It has been reported that for patients of smaller breast volume prone 
position might result in worse cardiac dosimetry than supine position [9-11]. In our patient 
group, even in patients of breast volume <750cc a heart D
max 
of <10Gy and
 
D
mean
 of <2Gy 
could be achieved with prone DIBH. Patients with smaller breast volume seem to benefit 
the most from prone DIBH. 
A concern of DIBH is replacing heart by lung tissue inside the irradiated volume. Slightly 
better lung dose metrics were obtained in prone SB compared to prone DIBH (GUH group), 
though in similar low dose ranges in which the contribution of scatter and transmission 
becomes significant. The lung volume increase seems to partially compensate for the 
eventual dose increase at a small volume part. Clearly, prone DIBH remains superior to 
any supine technique for lung sparing. 
Prone DIBH was clinically applicable without treatment interruptions; only one patient 
wasn’t able to perform prone DIBH due to abdominal pain during treatment. Random and 
systematic errors of prone DIBH after setup correction were in the order of 1 to 2 mm, 
which has also been observed for supine DIBH [29, 30]. Still for some patients higher setup 
errors up to 4.9 mm are documented (patient 27 in table 2). The current setup procedure 
for prone DIBH is quite intensive with daily CBCT in prone SB and kV-imaging in prone 
DIBH, fine-tuning of this procedure is currently investigated. Our results and others [13, 
26, 31, 32] confirm the ability of prone (DIBH) WBI to achieve an excellent acute toxicity 
profile, only 2/28 patients developed moist desquamation. 
In conclusion, prone DIBH combines the heart sparing effect of DIBH and the lung sparing 
ability of prone positioning, pointing to lower rates of heart toxicity and a lower potential of 
ipsilateral lung cancer induction for left-sided WBI. Fine-tuning and confirmation of prone 
DIBH WBI is needed to extrapolate this novel treatment approach into standard practice. 
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ABSTRACT
Introduction: Investigating reproducibility and instability of deep inspiration breath hold 
(DIBH) in the prone position to reduce heart dose for left-sided whole breast irradiation. 
Material and Methods: Thirty patients were included and underwent 2 prone DIBH CT-
scans during simulation. Overlap indices were calculated for the ipsilateral breast, heart 
and lungs to evaluate the anatomical reproducibility of the DIBH maneuver. The breath-
ing motion of 21 patients treated with prone DIBH were registered using magnetic probes. 
These breathing curves were investigated to gain data on intrafraction reproducibility and 
instability of the different DIBH cycles during treatment.
Results: Overlap index was 0.98 for the ipsilateral breast and 0.96 for heart and lungs 
between both DIBH-scans. The magnetic sensors reported population amplitudes of 
2.8±1.3mm for SB and 11.7±4.7mm for DIBH, an intrafraction standard deviation of 
1.0±0.4mm for DIBH, an intra-breath hold instability of 1.0±0.6mm and a treatment time 
of 300±69s.
Conclusion: Prone DIBH can be accurately clinically implemented with acceptable repro-
ducibility and stability. 
INTRODUCTION
Whole breast irradiation (WBI) after surgery in early-stage breast cancer patients can in-
duce severe complications including contralateral breast cancer, lung cancer and cardi-
ac toxicity [1-12]. These complications may potentially reduce the shown benefits of WBI 
on overall survival [13]. Therefore, recent research in the field of breast radiotherapy has 
focused on techniques lowering the dose to the organs at risk (OARs) while maintaining 
adequate dose coverage to the ipsilateral breast. In supine position, the breast enwraps 
the heart and ipsilateral lung and is flanked by the contralateral breast permitting only 
limited beam access without traversing these OARs. Due to this proximity, dose reductions 
to one OAR without compromising dose to other OARs are only possible to a certain extent. 
Deep inspiration breath hold (DIBH) has been described in supine position to significant-
ly lower heart dose metrics by increasing the heart-breast distance for patients receiving 
left-sided WBI [14-18]. An alternative to supine setup is prone position, which exploits 
anatomical changes due to gravitation and has been shown to significantly decrease lung 
dose in all patients and heart dose in the majority of patients compared to the standard 
supine position [19-28]. 
This trial is a part of a phase I-II study combining the advantages of DIBH and prone positioning 
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for left-sided WBI. Prone DIBH enabled to lower mean heart dose to <2Gy in 96% and 
maximum heart dose to <10Gy in 94% of patients; while, for prone normal or shallow 
breathing (SB), this was only achieved in 52% and 36%of patients, respectively. Moreover 
the lung sparing ability of prone positioning was preserved (paper submitted). Dosimetric 
advantages of a novel treatment technique can only be extrapolated into a clinical benefit 
when accurate clinical execution can be guaranteed; this trial describes the reproducibility 
and stability of DIBH in the prone position for left-sided WBI. 
MATERIALS AND METHODS
This study was designed as a prospective, mono-centric feasibility trial approved by the 
Ethics Committee of the Ghent university hospital.
Thirty consecutive female left-sided breast cancer patients were included after informed 
written consent. All patients underwent breast-conserving surgery, were lymph node neg-
ative and eligible for adjuvant left-sided WBI. All patients underwent CT-simulation; the last 
22 patients were accepted for prone DIBH WBI treatment. One of the 22 patients wasn’t 
able to perform prone treatment due to abdominal pain and was re-simulated and treated 
in supine position. 
Prone (-lateral) positioning was performed on a modified prone breast board (Orfit In-
dustries, Wijnegem, Belgium) using a unilateral breast holder developed by Van de Velde 
(Schellebelle, Belgium) [27]. The patient’s breathing motion was registered using 2 Respis-
ens magnetic sensors (Nomics, Angleur, Belgium) placed at the breast board and lateral 
thoracic wall [24, 27, 29]. The voluntary DIBH-maneuver consisting of two introductory 
non-deep breaths followed by a deep inspiration and a breath hold phase was reported 
previously by Remouchamps et al. [29]. The different DIBH cycles during simulation and 
treatment were instructed using verbal audio coaching. During simulation, one prone SB 
and two prone DIBH CT-scans were acquired as shown in figure 1. Neither patient posi-
tioning nor scan range were altered, therefore assuring that the DICOM coordinate sys-
tem, indicated by the frame of reference UID of the different scans, remained identical. 
The first DIBH scan (DIBH1) was used for treatment purposes. The second scan (DIBH2), 
with adapted CT-scan parameters to minimize radiation exposure to the patient, was used 
to verify the anatomical reproducibility of prone DIBH. The images were transferred to a 
Pinnacle planning station (Philips Medical Systems, Andover, US) and delineation of the 
heart, both breasts and lungs was done on SB, DIBH1 and DIBH2 CT datasets as re-
ported in previous publications [23-25, 27]. Rigid registration of the DIBH1 and DIBH2 CT-
scans evaluated the reproducibility of the anatomical changes induced by performing the 
DIBH maneuver. DIBH1
 
and DIBH2 were fused based on the DICOM coordinates and the 
overlap index was calculated for the ipsilateral breast, heart and both lungs. The overlap 
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index was defined as the intersection of the volumes on DIBH1 (VDIBH1) and DIBH2 (VDIBH2) 
divided by the volume on DIBH1 (VDIBH1) [23]:  
Overlap index = VDIBH1 ∩ VDIBH2 / VDIBH1 
The higher the anatomical reproducibility, the higher the overlap index.
Figure 1.:  During simulation, one prone shallow breathing (SB) followed by two prone DIBH CT-scans were 
taken without altering the scan range. The second prone DIBH (DIBH2) CT-scan was acquired with 
adapted parameters to minimize radiation exposure to the patient. Overlap indices were calculated 
by rigid registration of DIBH1 and DIBH2.
Twenty-one patients were treated on an Elekta Synergy linear accelerator (Elekta, Crawley, 
West-Sussex, United Kingdom) using a hypofractionated WBI schedule of 15 fractions. 
If required a sequential boost was given in 4 to 6 fractions according to the department’s 
guidelines. Figure 2 (upper part) provides the typical breathing curve during one treat-
ment session recorded with the Respisens probes. The breathing curves registered by the 
Respisens system was used to analyze the reproducibility and stability of the breath hold 
amplitude. In-house C++ software was used to analyze the Respisens data. The noise of 
the Respisens dataset was initially reduced using a symmetric 25-points Savitzky-Golay 
filter [30] and normalized to an average amplitude. A Cholesky decomposition was used 
to fit a second degree polynomial, which was subtracted from the amplitude to obtain a 
trend-corrected dataset, which was used to compute the maximum inspiration and expi-
ration time per breathing cycle based on the method described by Veldeman et al. [24]. 
The amplitude of each inspiration and expiration time was determined on the non trend- 
corrected data. 
81
§ 7.  PU BL ICAT ION 5
Figure 2.:  Graphical output from the Respisens system of a typical sequence of prone deep inspiration breath 
holds (DIBH).The horizontal axis defines time (t), the vertical axis amplitude (A). The upper part 
demonstrates a typical breathing curve during treatment. kV-kV imaging (Im) was used to correct trans-
lational errors of DIBH (between Im-T1). Afterwards different DIBH-maneuvers (T1-T5) were performed 
for irradiation, note the gap between T3 and T4 to rotate the gantry. The SB-range was defined to cal-
culate the SB-amplitude. The lower part shows the details of a DIBH-maneuver with two preparatory 
breaths followed by deep inspiration and breath hold during approximately 15 seconds. A systematic 
peak is visible at the beginning (B) as well as a smaller peak at the end (after E). The following param-
eters, A till E, are assessed to gain data on prone DIBH amplitude, instability and time. 
Prone SB:
A shallow breathing range was selected to compute all minimum and maximum amplitudes. The 
SB amplitude was calculated as the difference between the average of all minima and maxima. 
Prone DIBH:
Characteristically, as shown in figure 2 (lower part), within one breath hold phase there are 
2 peaks caused by the contraction and relaxation of the thoracic muscles; one prominent 
at the beginning (B-C) and one less pronounced at the end (after E). The time and ampli-
tude of maximum expiration and inspiration (A and B, respectively) was computed based 
on the minima and maxima as explained above. The duration of the breath hold-range 
(B till E; without the end-peak) was measured for each non-imaging DIBH phase (Tn). 
Afterwards, the peak at the beginning (between B and C) of the breath hold was subtract-
ed for each breath hold-range.
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- The intra-breath hold instability was calculated as the difference between the upper (C) 
and lower (E) values inside a breath hold.
- The DIBH amplitude was defined as the difference between the average (D) of (C) and 
(E) and the end-expiration through (A) preceding the breath hold.
The average and standard deviation of the DIBH amplitudes and intra-breath hold insta-
bility were calculated for each treatment session to evaluate intra-fraction DIBH reproduc-
ibility and instability. The DIBH-time was registered from A till E for each DIBH-maneuver; 
the treatment time was recorded from A of the first (T1) till E of the last (Tn) DIBH phase.
RESULTS
Patient characteristics are presented in table 1. 
Patient Age BMI Pack year Vbreast
1 52 24 0 775
2 66 29 0 1153
3 72 25 0 690
4 51 24 14 465
5 64 26 0 1937
6 47 21 20 1379
7 71 28 0 960
8 40 25 0 869
1 50 28 10 907
2 55 35 30 862
3 51 35 5 2372
4 66 31 0 2060
5 64 29 0 663
6 55 23 0 954
7 50 26 4 556
8 49 24 30 929
9 50 20 2 485
10 61 31 25 1101
11 49 27 30 1159
12 51 38 7 2372
13 54 31 36 1728
14 62 25 0 1001
15 64 29 20 737
16 44 31 14 1831
17 55 27 0 677
18 55 21 0 627
19 40 17 11 176
20 52 24 10 640
21 68 30 38 1284
# 57 39 14 2637
Table 1.: Patient characteristics.
Thirty patients were included. All patients underwent deep inspiration breath hold (DIBH) cycles in the prone po-
sition during simulation. Twenty-two patients were accepted for prone DIBH treatment; one patient indicated with 
# wasn’t able to perform prone positioning during treatment. Abbreviations: BMI = body mass index; Pack year 
= smoking history expressed as pack year; Vbreast = breast volume.
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All patients underwent CT-simulation including 2 prone DIBH CT-scans. The overlap index 
(mean ± standard deviation) between DIBH1 and DIBH2 was 0.98±0.04 for the ipsilateral 
breast, 0.96±0.06 for the heart, 0.96±0.03 for lung left and 0.96±0.04 for lung right. Total 
lung volumes were 2748±452cc, 4239±810cc and 4228±802cc for SB, DIBH1 and DIBH2, 
respectively. Lung volumes between both DIBH-scans did not differ (p=0.7 by the paired t-test).  
Twenty-one patients were treated with prone DIBH. The Respisens data are presented in 
table 2. The population amplitude of the DIBH was 4 times larger than the SB, showing the 
ability of patients to perform a deep breath in prone position. The intra-fraction standard 
deviation of the DIBH amplitude was 1.0±0.4mm (range 0.5-1.9mm). This illustrates the 
high reproducibility of breath hold amplitudes during one treatment fraction. The instability 
of the DIBH, i.e. the difference in breath hold amplitude between the beginning and the end 
of one breath hold (without the peaks), was <2mm in 19/21 patients (range 0.1 – 2.9 mm) 
with a mean intra-fraction SD of <1mm in all patients. This corresponds with an intra-breath 
hold instability of <10% (9±4%) of the total prone DIBH amplitude. The number of breath 
holds required to deliver the treatment ranged from 4 to 7, each lasting on average 16±1s. 
For imaging 1 or 2 additional DIBH maneuvers were required. This resulted in a treatment 
time of 300±69s (range 231-445s). 
Patient ASB (mm) ADIBH (mm) IDIBH (mm) N tDIBH tT
Mean Mean Ia SD Mean Ia SD (seconds) (seconds)
1 3.0 12.0 0.9 1.5 0.7 6 16±2 385±43
2 3.6 8.4 0.8 1.4 0.5 4 15±1 235±33
3 1.9 15.8 0.9 1.0 0.3 5 16±1 292±21
4 0.9 6.4 0.6 0.4 0.2 7 18±2 445±34
5 1.6 12.2 1.4 0.9 0.4 4 16±1 239±23
6 2.9 24.4 1.3 1.3 0.8 4 18±2 291±89
7 1.7 10.8 1.0 1.0 0.4 4 17±2 242±66
8 2.1 5.7 0.8 0.4 0.1 4 16±2 238±15
9 6.8 12.4 1.1 1.1 0.4 4 17±1 231±12
10 3.7 10.7 1.0 1.1 0.3 5 16±1 308±37
11 2.2 13.4 0.9 0.9 0.2 4 17±0 234±29
12 3.9 13.0 0.8 2.0 0.3 4 16±1 247±20
13 2.7 8.8 1.0 1.3 0.5 5 15±1 288±49
14 3.8 11.1 0.8 0.6 0.3 5 18±2 407±202
15 2.4 10.2 1.2 0.9 0.3 5 14±0 345±118
16 1.4 7.4 0.6 0.3 0.1 6 16±2 305±30
17 3.4 15.3 1.6 2.9 0.9 5 16±1 314±96
18 4.0 21.6 1.9 1.6 0.7 5 15±1 438±85
19 2.6 9.6 0.8 0.6 0.5 4 15±1 231±43
20 2.4 10.7 1.6 0.1 0.3 4 18±1 256±19
21 2.6 6.2 0.5 0.4 0.2 5 14±1 338±126
Population 2.8±1.3    11.7±4.7     1.0±0.4      1.0±0.6                0.4±0.2 5±1 16±1               300±69    
Table 2. Respiration data recorded with the Respisens system during treatment.  
Individual and population averages for mean and intrafraction standard deviation (Ia SD) for shallow breathing 
(SB) amplitude (ASB), deep inspiration breath hold (DIBH) amplitude (ADIBH) and instability (IDIBH). The number of 
DIBHs required for treatment is indicated by N, mean and standard deviations are displayed for DIBH (tDIBH) and 
treatment time (tT).
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DISCUSSION
RT is part of the standard treatment for early breast cancer after breast conserving sur-
gery. Though it is also associated with severe side effects to heart, lungs and contralater-
al breast [1-12]. DIBH has been shown to be an effective technique to lower heart dose 
in supine position [14-18], while prone position is clearly the preferred technique for lung 
sparing [19-25]. By performing prone DIBH we were able to combine the advantages of 
both entities. This trial focuses on the accuracy of reproducibility and instability of DIBH in 
the prone position during simulation and treatment. 
Despite the heterogeneous patient group (table 1); all 30 patients were able to perform 
prone breath hold maneuvers during simulation. One of the 22 patients addressed for 
prone DIBH treatment couldn’t tolerate prone position during treatment due to discomfort. 
Since prone DIBH treatment is expected to take more time than a standard prone treat-
ment, complaints due to prone positioning [25, 31-33] can be of more importance. Still 
21 of the 22 patients were able to perform repetitive breath hold cycles (range 4-7) of on 
average 14-18 seconds during treatment. A mean increase in total lung volume of approx-
imately 50% was seen and breath hold amplitudes were on average 4 times higher than 
SB amplitudes, illustrating the feasibility of DIBH in the prone position. 
Reproducibility and instability of supine DIBH appears to be in the order of a few millime-
ters as reported in different studies [34-37]. Our data suggest similar high reproducibility 
of the prone DIBH technique. Overlap indices of ≥0.96 for breast, heart and lungs indicate 
a high rate of intra-fractional anatomical reproducibility during simulation. There is a 4-fold 
increase in amplitude by performing DIBH compared to SB. The intra-fraction SD of the 
breath hold amplitude was less then 2mm in all patients, illustrating the high reproducibil-
ity of the breath hold amplitudes during treatment. The instability of the amplitude during 
one breath hold was 1.0±0.6mm for the whole population, which is <10% of the DIBH am-
plitude. This instability is quite consistent indicated by the very low intrafraction standard 
deviation of 0.4mm. 
CONCLUSIONS
DIBH for prone left-sided WBI is achievable with accurate reproducibility and stability dur-
ing simulation and treatment. Further research is needed to validate these results in order 
to implement prone DIBH in daily practice. 
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CHAPTER 8: DISCUSSION 
8.1 HAVE THE OBJECTIVES OF THIS THESIS BEEN ACHIEVED?
8.1.1 Determining the best radiation technique  
   for prone and supine WBI
In chapter 3 we investigated the consequences of MB-IMRT, TF-IMRT and W-TF by indi-
vidual comparison in the prone and supine positions. In agreement with others [1-5], IMRT 
was able to reduce dose inhomogeneity compared to conventional W-TF, though differ-
ences were rather small and more dependent on positioning. MB-IMRT was established 
as the preferred technique in supine position [6-8], though even with this technique prone 
enabled better conformity indices, target dose distribution and lung sparing [9-18]. Heart 
dose metrics were consistently better in prone position for large breasted patients [11-
13], while for patients with smaller breasts heart dose metrics were comparable or worse 
compared to supine MB-IMRT. None of our selected primary beams pass through the het-
erolateral breast regardless of technique or positioning. Little differences were observed 
between the different radiation techniques in prone position. This might be of interest for 
other centres wanting to implement prone WBI: there is no need for advanced techniques 
to exploit the superiority of prone WBI. 
8.1.2 Enhancing clinical feasibility of prone WBI
Prone WBI was first tested at Ghent University Hospital in 2008. Over the years, a prone 
IMRT technique was developed which could be routinely used. A commercially available 
breast board was modified and a unilateral breast holder was developed to retract the het-
erolateral breast [14, 15]. However, before implementing the technique in daily practice 
some problems had to be solved. Patient comfort on the breast board was suboptimal and 
the performance of the cone-beam CT to assess setup errors was improved but still not 
ideal. Therefore some adjustments had to be made in order to optimize clinical feasibility. 
8.1.2.1 Unilateral breast holder & breast board  
We observed in some patients thoracic/abdominal folds under the treated breast in prone 
position. These folds are at risk of being in the radiation field. Therefore, the submammary 
elastic belt of the unilateral breast holder was widened and reinforced in cooperation with 
Van de Velde (Schellebelle, Belgium). 
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Figure 8.1A:  Unilateral breast holder to retract the contralateral breast away from the treated breast.  
The sub-mammary elastic red belt reduces thoracic/abdominal skin folds. 
A new breast board was developed in collaboration with Orfit Industries (Wijnegem, Belgium) 
in order to improve patient comfort, setup easiness and reproducibility. Their commercially 
available breast board was used as a starting point, but a sloping surface was created to 
force the patient into a prone lateral position by using a carbon fibre wedge support for 
the contralateral breast and by using wedged-shaped elevation cushions. The head rest 
was also changed to improve patient comfort. A numeric scale to adjust the table height 
using the in room laser and a safety belt were added to the design. The most important 
difference with the modified Horizon breast board we used in the past [14, 15] is the arm 
position which is more comfortable for the patient and the ipsilateral shoulder which is now 
supported by the breast board.
Figure 8.1B: Prone breast board: 1: hand grip; 2: head rest; 3: carbon fiber wedge support of the contra-lateral 
breast; 4: numeric scale (at both sides of the caudal part) to adjust table height using the in-room 
laser system; 5: safety belt. The wedge support and elevation cushions force the patient into a roll of 
≈15°. The treated breast hangs freely between the cranial and caudal parts of the breast board with 
unobstructed access for radiation beams from both sides.
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8.1.2.2 Cone beam CT 
In chapter 4 we updated the current existing CBCT parameters in order to improve surface 
reconstruction, radiation exposure and clinical workflow for supine and prone breast radio- 
therapy. The established CBCT acquisition parameters (180° rotation, small FOV, bowtie 
filtration, tube current of 20 mA and exposure time of 32 ms) result in (1) an adequate con-
tour accuracy, (2) decrease the radiation burden to the patient and (3) eliminate the offset 
patient positioning procedure. It has now evolved into a robust quality control procedure 
and is used as standard practice for breast RT at GUH. 
8.1.3 Clinical and dosimetric validation of prone WBI
8.1.3.1 Ipsilateral breast
Up to 40% of patients develop non-neglectable acute or late ipsilateral breast toxicity due 
to breast irradiation [1, 2, 19]. Figure 8.2 displays different grades of dermatitis and des-
quamation due to breast RT. Desquamation was scored as 0 = none, 1 = dry and, 2 = moist. 
Dermatitis was documented using the common terminology criteria for adverse events v3.0. 
Dermatitis was evaluated as 0 = none, 1 = faint erythema or dry desquamation, 2 = moderate 
to brisk erythema; patchy moist desquamation mostly confined to the skin folds and creases 
and 3 = moist desquamation other than skin folds and creases, bleeding induced by minor 
trauma or abrasion.
Figure 8.2.: Desquamation (A; 1=dry, 2=moist) and dermatitis (B; grade 1, 2, 3) due to breast irradiation.
	   	  
                                        1            2                                 
                                         
	   	   	  
                    1        2                      3   
A) Desquamation. 
B) Dermatitis.
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Impaired target dose distribution has been linked with breast toxicity [1-3, 20, 21]. Our 
clinical randomized trial confirmed the correlation between adverse target dose distribu-
tion parameters and acute toxicity. The presence of high dose regions >105% and >107% 
of the prescription dose was associated with desquamation, dermatitis, edema and pain. 
Dose homogeneity <85% was related with dermatitis; <90% with edema and pain (chapter 
5). The radiological pathlengths traversing the breast are reduced due to narrowing of the 
breast in prone position; resulting in less dose fluctuations within the target as shown in our 
results (chapter 3/5) or by others [9, 10, 22]. The antero-medial shift of the lateral border 
of the breast in prone position allows a more conformal dose and less of the prescription 
dose in non-target tissue (especially towards the shoulder region). Furthermore prone 
position restores build-up effect by unfolding the skin folds, especially in the inframamma-
ry and axillary region. 
The improved target dose distribution due to prone positioning results in less acute toxicity 
in large breasted patients as shown in our randomized trial (chapter 5). A 3-fold reduction 
of moist desquamation was observed from 20% (10/50) of the supine treated patients to 
6% (3/50) in the prone cohort. Grade 3 dermatitis, i.e. moist desquamation outside the 
skin folds, was absent in prone position, while it occurred in 4% of patients treated in 
supine position. Dermatitis grade 2/3 was halved (19/50 versus 40/50 patients) in the 
prone group. Edema, pruritus and pain occurred less frequently and were less severe in 
the prone compared to the supine population. Our data (chapter 5/6) are comparable with 
others [22-25] and confirm the excellent acute toxicity profile of prone WBI. Chronic skin 
toxicity and cosmesis of these patients is assessed with digital photographs and will be 
evaluated in a future stage.
8.1.3.2 Lungs
Lung toxicity is an important iatrogenic effect of breast RT (chapter 1.2.3) There is a marked 
increase of ipsilateral versus contralateral lung cancer mortality after breast irradiation 
increasing with time from diagnosis [26-29]. In the study of Henson et al. [29] the mortal-
ity from radiation induced lung cancer (ipsilateral versus contralateral) exceeds mortality 
from cardiac radiation injury (left-sided versus right-sided irradiation) for patients treated 
after 1983. 
Prone position elongates the breast away from the chest wall region and reduces the vol-
ume of intra-thoracic irradiation. Our results demonstrate an at least 4-fold decrease in 
mean ipsilateral lung dose based on population (chapter 5) and individual comparisons 
(chapter 3/6), being consistent with other published data [10-18]. Extrapolation of the data 
of Grantzau et al. [30] on our randomized trial (chapter 5) results in a decrease of relative 
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risk of 153% (for non-smokers) and 311% (smokers) of secondary lung cancer in the 
highest lung dose region. Still the absolute amount of radiation induced lung cancer after 
breast RT remains low. 
8.1.3.3 The cardiac dilemma
During this thesis we had the opportunity to work at Clinique et Maternité Sainte-Elisabeth 
(CMSE), Namur; where DIBH is routinely used as standard practice whenever the primary 
beams intersect the heart for supine WBI [33-35]. Previous dosimetric comparisons [10-18] 
between supine and prone WBI were only performed using non-respiration-related 
techniques. Our purpose was to compare prone SB with supine DIBH for left-sided WBI. 
Our secondary objective was to explore potential effects on heart dose metrics by com-
bining the prone experience from the GUH with the DIBH experience of CMSE Namur. 
To our knowledge, prone DIBH has not been investigated before. We expected only minor 
effects on heart dose of prone breathing adapted RT compared to prone SB due to the 
limited respiration related movement of the breast in prone position. 
 
In a pilot phase we scanned 12 patients in SB and DIBH in the prone and supine position at 
CMSE Namur. In both positions DIBH demonstrated to be a powerful technique to reduce 
Henson et al. [29] reported that patients treated after 1983 had no increased risk of cardiac 
mortality; nevertheless vigilance is required since cardiac injury is still reported [31] and 
risk ratios of heart mortality increase over time since RT [29]. Moreover, a recent trial from 
Darby et al. [32] observed a linear relationship between rates of major coronary events 
and mean heart dose, with no apparent threshold dose.
As mentioned above, MB-IMRT is the preferred technique for heart sparing in supine posi-
tion [6-8]; however prone WBI, irrespective of radiation technique, enables better population 
averages for heart dose metrics; though non-significantly. Our results (chapter 3/5/6) are in 
agreement with other publications [10-12, 14, 16-18] and confirm the ability of prone posi-
tion to reduce heart dose metrics for the majority of patients, especially for large breasted 
patients. Based on extrapolation of Darby’s findings [32], a risk reduction of 3.7% of major 
coronary events in our large breasted prone cohort is estimated (chapter 5). 
Based on the data from the randomized trial, prone WBI became the standard treatment 
technique at GUH for all right-sided breast cancer patients and for left-sided patients with 
a cup size C or more. For small-breasted left-sided patients prone IMRT is not consistently 
better regarding heart dose. For some patients, it results in a significantly higher heart dose 
compared to supine WBI. Therefore, prone position was not routinely used for left WBI in 
patients with a cup size A or B. 
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cardiac irradiation, while for prone DIBH the advantages of prone positioning on lung spar-
ing were preserved. In a second phase we transferred the prone DIBH technique to GUH 
where we scanned an additional 38 patients in prone SB and DIBH as a validation cohort. 
Pooling the data for prone position, a mean heart dose reduction of 0.9 Gy was observed 
with prone DIBH compared to prone SB. A mean heart dose of <2 Gy was achieved in 
48/50 patients with prone DIBH, even in patients with a small breast volume. The effect 
of DIBH is caused by a caudal movement of the heart triggered by the contraction of the 
diaphragm rather then a displacement of the breast target volume as shown in figure 8.3.
 
The reproducibility of prone DIBH was shown in chapter 7. Thirty patients were evaluated; 
the first 8 patients were used to get experience with DIBH in a simulation procedure, the 
next 22 patients were accepted for the prone DIBH treatment protocol. All patients were 
able to perform the simulation part, one patient wasn’t able to perform prone positioning 
during treatment and was treated in supine SB. Data on reproducibility were collected 
from the 2 prone DIBH CT- scans during simulation and magnetic sensors during treat-
ment. All measurements pointed to acceptable intrafraction reproducibility and stability of 
the procedure (chapter 6 & 7). Prone DIBH offers the opportunity to avoid heart and lung 
tissue in the primary radiation beam. In an ongoing trial at GUH, patients presenting for 
prone left-sided WBI are scanned with and without DIBH to gain more experience with the 
procedure and to identify patients that benefit from the technique.
Figure 8.3.: Anatomical consequences of DIBH in the prone position. The heart and ipsilateral breast are  
 delineated in red and yellow for prone SB, in green and purple for prone DIBH, respectively.
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8.1.4 Limitations of prone WBI
Presently, patients requiring WBI without lymph node irradiation are offered prone 
treatment at GUH, either in daily routine or in ongoing trials. Introduction of WBI in the 
prone position over the past 6 years was a steep learning curve. However there is much 
room for improvement. 
Prone position and positioning might be occasionally difficult, especially for older rigid 
patients with large breasts. Despite the introduction of a more comfortable breast board, 
neck/shoulder/rib discomfort is reported. This especially for procedures that expand treat-
ment time, like DIBH. Currently we are constructing a novel breast board. Our aim is to: 
(1) allow prone whole breast + lymph node irradiation, (2) enhance patient comfort and 
setup reproducibility.
Setup precision is comparable with supine WBI except for lateral errors that are often 
higher in prone position. Moreover we use daily CBCT in order to compensate for these 
setup inaccuracies. 
The current prone DIBH procedure is quite intensive and time consuming evoking the 
assumption of a higher treatment cost. Treatment delivery is the most important component 
of treatment-related activities; being responsible for the biggest share in radiotherapy 
resource cost. Consequently prolongation of total treatment time is detrimental from a 
financial point of view for RT departments [36]. Treatment slots for supine/prone SB WBI 
are 20 minutes; while for prone DIBH WBI this is 25 minutes or even 30 minutes in the 
simultaneously integrated boost (SIB) trial. Currently we use a hypofractionated schedule 
of 15 fractions for WBI according to the START B trial [37] compared to normofractiona-
tion schedule of 25 fractions, which we used several years ago. This translates into a de-
crease of total treatment time of 125 minutes for DIBH and 200 minutes for SB compared 
to previous years, which might offset the assumed higher treatment cost of prone DIBH 
compared to the older regime. Moreover we are investigating SIB (chapter 8.2.1) with the 
assumption to further decrease the amount of fractions and thus treatment cost. In this 
trial evaluation of the cost effectiveness will be objectively assessed [38].
We are also fine-tuning the DIBH procedure to make it more applicable in other centres. Currently 
we are investigating whether we could reduce the CBCT imaging time to <15-20 seconds in order 
to perform the CBCT in prone DIBH and avoid one additional DIBH cycle. It is also investigated 
whether daily DIBH kV-imaging is needed since random and systematic errors were in the order 
of 1 to 2 mm for the majority of patients (chapter 6). Still, prone DIBH will be hard to implement 
for all patients. We are currently investigating which patients benefit the most from the technique. 
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8.2 CURRENT AND FUTURE RESEARCH
8.2.1  Use of prone DIBH in a simultaneous integrated vs.  
    sequential boost randomized trial
The use of prone DIBH technique is further applied and evaluated in left-sided patients 
included in a randomized trial comparing a sequential boost (SeqB) with a simultaneous 
integrated boost (SIB). Left-sided patients are simulated in prone SB and DIBH and when-
ever the mean heart dose exceeds 2Gy and/or maximum heart dose exceeds 10Gy in SB, 
prone DIBH is performed during treatment. 
After WBI, a SeqB dose to the tumour bed further improves local control [39]. A SeqB is 
typically given in 4 to 8 extra fractions, which prolongs the overall treatment time. Prone 
IMRT offers the possibility to deliver the boost dose within the 15 fractions of WBI, the 
so-called SIB. SIB shortens the overall treatment time, which is convenient for the patient 
and the radiotherapy department. In the randomized trial the hypothesis of acceptable 
skin toxicity and reduced cost with SIB using prone IMRT with topographical dose painting 
(TDP) is tested. TDP is a technique recently developed in our group in which the dose is 
modulated across the breast depending on the risk of microscopic tumor spread. TDP is 
a variant of signal-intensity dose-painting [40]. 
8.2.2 The use of prone gated techniques for WBI
At CMSE Namur we wish to explore respiratory gating for prone WBI: 
• In a first phase we evaluated the feasibility of prone gating in a simulation pro-
cedure resulting in 80% of patients having a maximum heart dose of <10Gy 
in the end-inspiratory phase [41].
• In a second phase, prone SB, prone DIBH and prone inspiratory gating will 
be evaluated regarding heart dose. Our hypothesis is that different respirato-
ry techniques could lower heart dose metrics in the prone position, however 
it is unclear which method is the most powerful. Whenever mean heart dose 
exceeds 2Gy and/or maximum heart dose exceeds 10Gy in SB, prone DIBH 
will be executed during treatment.
• In a third phase prone DIBH and inspiratory gating will be compared with 
respect to patient comfort, setup accuracy and reproducibility during treat-
ment using a daily alternating scheme. 
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8.2.3 Prone nodal irradiation 
The advantages of prone WBI are accumulating though the role of prone positioning for 
nodal irradiation is unclear. Our hypothesis is that the dosimetric benefits of prone WBI can 
be translated to patients needing nodal irradiation. Prone whole breast with lymph node 
irradiation necessitates the development of a new positioning device. Our goal is to devel-
op a dedicated breast board appropriate for prone nodal irradiation using Thiel-embalmed 
cadavers. The technique of DIBH for prone whole breast and lymph node irradiation will 
be investigated. 
8.2.4 Documentation of endpoints
Dosimetric advantages of novel techniques are only useful when this can be translat-
ed into clinical benefits. It is our goal to prospectively follow the patients and document 
co-morbidities. Patients our monitored one-to-two weeks after completion of their RT then 
every six month’s during the first year and afterwards yearly. It is our purpose to document 
acute and late breast ipsilateral toxicity using photographs. As pointed out by Professor De 
Meerleer, we might not have documented all radiotherapy induced side effects. Rib cage 
problems including rib fractures are reported in literature after breast radiotherapy [42-48], 
we will document this toxicity in the future. We also wish to evaluate late toxicity including 
secondary cancers and heart toxicity; still the method of evaluation is under discussion.
8.3 CONCLUSIONS
This thesis strengthens the evidence of replacing the standard supine treatment by prone 
(DIBH) WBI. It confirms the advantages of prone WBI on target dosimetry and lung spar-
ing [9-18]. Moreover a reduced frequency and severity of acute toxicity was observed in 
a prone cohort compared to a supine cohort in a randomized trial with large breasted 
patients. Improvement of heart dose could not be demonstrated in all patients by prone 
positioning [10-12, 14, 16-18]. By uniting DIBH and prone positioning we were able to com-
bine the benefits of both entities resulting in better heart and lung dosimetry for left-sided 
WBI. Fine-tuning of prone DIBH is needed to extrapolate this novel treatment approach into 
standard practice. Registration of late breast toxicity, cardiac comorbidities and secondary 
cancer induction is warranted in order to document the clinical advantages of prone (DIBH) 
WBI. We are collecting data prospectively in order to analyse these statements in the future.
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